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Abstract of the Dissertation 
The synthesis of ethers and thioethers is necessary as the motifs are ubiquitous in natural 
products, pharmaceuticals, and are quite useful in numerous synthetic applications. While 
common methodologies exists to prepare simple ether and thioether substrates, the harsh 
conditions of these techniques make them unsuitable for complex molecules. The requirement 
for facile and efficient means has led to an investigation into O - and S – alkylations occurring 
solely under thermal conditions utilizing trichloroacetimidates without the addition of a strong 
acid or base promoter. 
The alkylation of thiols by the direct displacement of trichloroacetimidates has been 
accomplished under thermal conditions (heating in refluxing THF). These reactions proceed to 
the corresponding thioetherification product without the requirement of an added acid, base, or 
metal catalyst. This facile procedure provides the sulfide in excellent yields with only the 
formation of the neutral trichloroacetamide as the side product. Formation of the 
trichloroacetimidate in situ has also been studied, which provides a convenient method for the 
formation of sulfides from alcohols in a single flask.  
 A similar methodology towards obtaining etherification products has also been 
investigated. O – Diphenylmethyl and para-methoxybenzyl trichloroacetimidates in refluxing 
solvent has shown to effectively convert a variety of alcohols to their corresponding ether 
without disturbing pre-existing functionality. This methodology provides the subsequent 
etherification products in moderate to excellent yields with only the formation of the neutral 
trichloroacetamide as the side product. 
 Additionally, the development of a more efficient and concise total synthesis towards the 
SHIP1 activator AQX-1125 from trans-dehydroandrosterone has been studied. The synthetic 
approach features an allylic oxidation of the C7 position and ozonolysis to generate key 
intermediates. Alternative routes have also been proposed and future investigations will aim to 
complete this project in the future. 
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Chapter 1. Trichloroacetimidates in Etherification and Thioetherification 
 
 
1.1 Introduction 
 
 
The ether motif is ubiquitous throughout organic chemistry, being common in numerous 
natural products, pharmaceuticals, and agrochemicals.
1-9
 The generation of an ether plays an 
important role in synthetic organic chemistry as oxygen is one of the most abundant heteroatoms 
in organic products. Ether formation also plays a key role in the protection of alcohols, another 
common organic functional group. For example, benzyl ethers are among the most common 
protecting groups in utilized in organic synthesis. Ethers are also commonly found in 
pharmaceuticals, such as those shown in Figure 1 below.
 8-79
 
 
Figure 1: Selected Pharmaceuticals that Contain Ethers  
 
The sulfur analogs of ethers, thioethers or sulfides, also play an important role in modern 
medicinal chemistry. Recent data mining efforts have shown that 48% of all new drugs approved 
between 2000 and 2010 contain sulfur.
80
 Organosulfur compounds are in clinical use for 
numerous medical conditions, such as cancer, diabetes, depression, AIDS, and arthritis, and have 
2 
 
also found use in antibacterial and anti-inflammatory applications.
80-86 
Some examples include 
Ticagrelor, a blood thinner, and Montelukast, which is used for the treatment of asthma (Figure 
2).
80 
Sulfides are also the precursors to sulfoxides and sulfones, which are useful functional 
groups in their own right, as demonstrated by the proton pump inhibitor Esomeprazole. 
 
Figure 2: Selected Organosulfur Pharmaceuticals 
 
Development of effective and practical methodology for the formation of ethers has 
received enormous attention.
 
 One of the earliest examples of a simple ether formation is via an 
acid-catalyzed condensation of alcohols; although primitive, it established a means to synthesize 
a symmetrical ether which is still widely used in industrial settings, frequently utilizing 
inexpensive primary alcohols. Secondary or tertiary alcohol substrates often yield elimination 
products instead of the desired ethers.
77,87,88
 
 
Scheme 1: Acid Mediated Etherification
 
 
3 
 
 Perhaps the most utilized methodology in ether and thioether syntheses takes advantage 
of base-mediated alkylation. Most commonly these reactions are variations on the Williamson 
ether synthesis, which occurs via a SN2 displacement of an alkyl halide or sulfonate by the 
respective alkoxide or thiolate.
77,87,88 
A stereotypical example is the anionic benzylation of α-D-
methyl-glucoside 11 with benzyl bromide and sodium hydride. This reaction has also been 
adapted to take place under near-neutral conditions utilizing barium oxide or silver oxide.
10,11,88
 
Additionally, there are well known examples of ether formation via transition-metal-catalyzed 
reactions, which include Ullmann
49-52
 and Buchwald-Hartwig reactions.
53-67
 
 
Scheme 2: Anionic Benzylation of α-D-methyl-glucoside 
 
These common methods are all valuable methodologies towards ether synthesis; although 
each has their respective disadvantages, like the requirement for expensive catalysts or that harsh 
reaction conditions that often limit the substrate scope.
79
 For example, the Williamson ether 
synthesis requires an alkoxide ion formation in the presence of a strong base
78,87,88 
and the 
Ullmann condensation towards etherification requires a copper catalyst in high-boiling solvent.
 
49-52
 These conditions are often not compatible with sensitive functional groups in polyfunctional 
molecules, and complex substrates often do not survive and/or multiple side products are 
generated. These limitations are especially relevant in the total synthesis of natural products, as 
these complex molecules often contain alcohols that need to be protected as ethers but the 
standard Williamson conditions lead to degradation and poor yields. 
 
 
 
 
4 
 
1.2 Trichloroacetimidates 
 
Trichloroacetimidates have emerged as useful alternative etherification reagents as they 
can be used in etherifications without the need for a strong base. Trichloroacetimidates are 
usually prepared by reaction of the inexpensive trichloroacetonitrile with an alkoxide ion, a 
method that was reported by Steinkopf and Malinowski
89, 90
 and later popularized by Cramer in 
the late 1950's by his inclusion of benzylic imidates.
91,92
 Notably, Overman and Schmidt have 
since modernized the method to prepare more complex trichloroacetimidates in polyfunctional 
molecules, using DBU and other amine bases instead of metal hydrides (Scheme 3).
10-12,78
 
Trichloroacetimidates typically require activation by an external promoter, commonly a Lewis or 
Brønsted acid like TfOH or TMSOTf, to undergo ether formation and therefore care must be 
exercised in their utilization in the presence of acid-sensitive functionality.
10,11,14
 
 
Scheme 3: Synthesis of Trichloroacetimidates 
 
Trichloroacetimidates have become known as a reliable means of installing benzyl, allyl 
and tert-butyl ethers, especially in base sensitive substrates.
93-95
 Additionally, numerous imidate-
type reagents have been developed, which include new trifluoroacetimidate
96, 97
 and 
phosphinimidate-based reagents.
98
  
5 
 
 
Figure 3: Commonly Used Trichloroacetimidates for Alcohol Protection 
 
The versatility of imidates in the installation of benzyl ethers is illustrated in the 
protection of benzoate 22 (Scheme 4). The O-benzoyl group rapidly migrates under basic 
conditions, leading to a mixture of products, while the trichloroacetimidate provides a single 
isomer of the carbohydrate derivative 23.
99,100 
Several other examples of the use of 
trichloroacetimidates in the protection of base sensitive substrates may also be found in the 
literature.
99
 
 
 
Scheme 4: Mild Benzylation Utilizing Benzyl Trichloroacetimidate 
 
 Although PMB and Bn imidate are two of the more well known examples, numerous 
trichloroacetimidates have been developed for use in etherification. Common imidates in 
etherification include: O – allyl, tert-butyl, phthalimidomethyl, diphenylmethyl, and 9-fluorenyl 
6 
 
trichloroacetimidates. All of these imidates may be used to install the corresponding ethers under 
mild reaction conditions in high yields in the presence of sensitive functionality.
10-12,79
 The 
advantage to using different types of ethers is that they may be removed under mild and/or 
orthogonal conditions, which makes them useful protecting groups for alcohols and facilitates 
complex synthetic pathways. 
Recent applications of imidates include the use of allylic imidate 17 in the protection of a 
key  intermediate in the synthesis of securinine,
101
 the use of phthalimidyl imidate 18 in the 
protection of glucose derivative 29,
102,103
 as well as the use of tert-butyl trichloroacetimidate 21, 
to synthesize the differentially protected diol 31 (Scheme 5).
104
 
 
Scheme 5: Selected Examples of Mild Alkylations Utilizing Trichloroacetimidates  
 
Trichloroacetimidates have also been used in the asymmetric synthesis of ethers. 
Overman has developed methodology utilizing palladium (II) catalysts, the cobalt oxazoline 
palladacycles (COP), to form some allylic ethers enantioselectively. These catalysts were 
originally developed for enantioselective imidate rearrangements to form allylic amines of high 
7 
 
enatiopurity.
105-115 
These catalysts have also shown facility at enantioselective allylic substitution 
reactions with phenols and carboxylic acids. 
 
Figure 4: COP Catalysts 
 
More specifically, Overman and co-workers have investigated the enantioselective allylic 
esterifications and etherifications, commonly utilizing COP-catalyst 33. Branched allyl esters are 
obtained in moderate to high yields with excellent enantiomeric purity and substrates bearing 
ester, ether, and silyl ether functionality tolerate this reaction well. Additionally, phenolic 
substrates were examined and obtained in good to excellent yields with high enantiomeric 
excesses. Both electron-donating and electron-withdrawing phenols participated in these 
reactions; however reaction times were noticeably longer than substitutions with carboxylic 
acids.
110-115
 
8 
Overman also performed kinetic and computational investigations into the likely 
mechanism of ether formation using COP catalysts. These studies found that the chelation of the 
basic imidate nitrogen to palladium(II) (as shown in 42 below), is critical for the selective C-O 
forming transformation (Scheme 6). Once complex 42 is formed, it is followed by alkene 
coordination to form chelated-cationic palladium (II) intermediate 42. Anti-acyloxypalladation 
by external nucleophilic attack at C3 generates intermediate 44. Subsequent syn-
deoxypalladation forms the alkene imidate complex 45. This complex then reacts with imidate 
41 and liberates the respective product and acetamide and allows for the regeneration of 
intermediate 42.
115
Table 1: Selected Examples of Asymmetric Synthesis of Allyl Aryl Ethers 
9 
Scheme 6: Catalytic Cycle for Pd
II
-catalyzed Allylic Esterification
In contrast to etherification, thioetherification with trichloroacetimidates is almost 
completely unknown outside of carbohydrate chemistry as only two examples of 
thioetherification has been recorded with trichloroacetimidates and these reactions only 
demonstrate the viability of the reaction with thiophenol.
116,117 
Schmidt's studies on the reactivity of the O-cyclopropylmethyl trichloroacetimidate were 
one of the first reports of sulfide formation with imidates and thiols outside the carbohydrate 
sphere. The O-cyclopropylmethyl trichloroacetimidate may form cyclopropylmethyl (Cpm), 
cyclobutyl (Cb), and/or homoallyl (Ha) products as all these structures may result from the 
rearrangement and trapping of the cyclopropylcarbinyl cation intermediate. Product formation in 
10 
these cases appears to be dependent on the nucleophilicity and steric demand of the reacting 
partner. Schmidt explains the results in Table 2 by rationalizing that the enhanced reactivity of 
thiol 49 results in a more rapid substitution reaction, providing only the cyclopropylmethyl 
alkylated product. In other cases when alcohols were used (like 47 and 48) significantly more 
rearrangement products were isolated (Table 2).
 116
A second example of thioether formation was mentioned by Zhu and co-workers in their 
studies of the hydroxyindole system shown below in Scheme 7. This imidate was formed in situ 
to provide a useful method to vary the structures at C-3 with different nucleophiles (Scheme 7). 
This alkylation is proposed to go through a stabilized cationic intermediate. Alcohols, phenols, 
amines, anilines, indoles, pyrroles, allyltin, and enol ether nucleophiles were effective in 
accessing the desired products, for example the para-Friedel-Craft products 50 and 52 were 
isolated in excellent yields. When thiophenol was utilized, however, a deviation in 
regioselectivity was seen in the case of compound 51, with substitution on the aromatic ring 
Table 2: Selected Examples of Alkylation with O-cyclopropylmethyl trichloroacetimidate 
11 
 
being derived from distal attack of the thiophenol on the aromatic ring. Blocking the site of 
attack with a chlorine resulted in the more common direct substitution product 53 (Scheme 9).
 117
  
This variation in reactivity is likely due to the increased nucleophilicity of sulfur in comparison 
to oxygen.
 
 
 
 
Scheme 7: Selected Examples of Nucleophilic Substitution of 3-Hydroxindoles
 
 
1.3  Glycosylation 
 
 Trichloroacetimidates have also been heavily utilized in the synthesis of glycosidic 
bonds, a reaction that has become very popular in oligosaccharide synthesis.
118-137
 Glycosyl 
trichloroacetimidates in carbohydrate synthesis were popularized by Schmidt after his disclosure 
in 1980 that they may function as a new type glycosyl donor (Scheme 8).
126-128
  
 
Scheme 8: Chemical Glycosylation 
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Typically the glycosyl imidates are formed by the reaction of the pyranose with 
trichloroacetonitrile and an added base.
128,130
 The advantage of utilizing trichloroacetimidates 
towards glycosidic bond formation is the facile nature of their preparation and the ease of their 
displacement, which often occurs with predictable selectivity for the - or - anomer.
 
 
Scheme 9: O - Glycosyl Trichloroacetimidate Formation 
 
The stereochemistry of the glycosylation reaction has been widely studied and is found to 
be dependent on the structure of the starting imidate; in many cases the reaction proceeds with 
inversion, although depending on the substrate, mixtures may also be observed (Scheme 12).
130 
Typical promoters for utilizing trichloroacetimidates for glycosylation reactions are strong Lewis 
Acids, commonly BF3•OEt2, AgOTf, ZnCl2, Sn(OTf)2, or TMSOTf.
 118-133
 However, more 
recently Brønsted acids have also been utilized towards oligosaccharide syntheses.
134-137
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Scheme 10: Oligosaccharide Synthesis Utilizing Trichloroacetimidates 
 
 In addition to O-alkylation towards oligosaccharide syntheses, Schmidt and numerous 
other groups have also investigated thioglycoside synthesis.
132,137-158
 Thioglycosides themselves 
are valuable intermediates in carbohydrate synthesis as they are considerably more stable to a 
wide range of reaction conditions, act as protecting groups, and can act as either a glycosyl donor 
or acceptor depending on reaction conditions.
133,138-159
 Varela and co-workers have recently 
depicted the versatility of imidates as glycosyl donors towards thiooligosaccharide synthesis 
using TMSOTf in hindered substrates, as depicted in Scheme 11.
159 
14 
 
 
 
Scheme 11: Thiooligosaccharide Synthesis Utilizing Trichloroacetimidates 
 
1.4 Specialized Etherification Reagents 
While trichloroacetimidates may be used to form ethers under mild conditions, the 
requirement of an acid catalyst may still be an issue with some very sensitive substrates. 
Consequently, several groups have investigated new O - alkylation methods that may occur 
under mild and near-neutral conditions.
10,11
 A special focus of this work has been in the 
installation of benzyl and substituted benzyl ethers, as these systems are commonly used to mask 
alcohols during complex synthetic schemes. Dudley and co-workers recently developed two 
alkylating agents for the protection of alcohols and carboxylic acids, benzyloxypyridinium 
triflate, 70,
 
and 2-(4-methoxybenzyloxy)-4-methylquinoline, 71.
14-21
 Reagent 70 is a bench stable 
solid that is synthesized from the corresponding pyridine and methyl triflate. Compound 70 
reacts with alcohols to form benzyl ethers in good yields without the need to add strong acid or 
15 
 
base. The lepidine derivative 71 is also effective at installing 4-methoxybenzyl ethers, but must 
first be activated in situ by the addition of methyl triflate. 
 
Figure 5: Dudley’s Alkylating Agents 
 
Some examples of the use of benzylating reagent 70 are shown below in Scheme 12.
14 
Primary, secondary and tertiary alcohols are benzylated under these reaction conditions. Phenols 
have also been shown to provide good yields of ether products. The formation of ethers 73 and 
75 are also notable, as 73 is known to undergo a facile retroaldol when treated with strong base, 
which precludes the formation of the benzyl ether under Williamson conditions, and 75 is subject 
to Peterson elimination. Previous attempts to form 75 employing imidate 15 and TfOH did not 
provide the desired ether. However this methodology did have limitations as seen with the more 
hindered tertiary substrate 76, which observed a significant decrease in yield and cholesterol 77 
and cinnamyl alcohol 78 did not yield any product. 
 
Scheme 12: Formation of Benzyl Ethers Using Benzyloxypyridinium triflate
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Dudley has also developed lepidine ether 71 for the formation of PMB ethers, which is 
reported to be significantly more stable than other PMB transfer reagents like PMB chloride and 
PMB trichloroacetimidate. When alcohols are treated with 71 and methyl triflate in refluxing 
-trifluorotoluene, the respective PMB ethers were formed in moderate to high yields; 
however tertiary and allylic alcohols were considerably less reactive (Scheme 13).
15
 Paquette and 
co-workers used a similar PMBO-lepidine derivative and conditions to serve as a surrogate for 
generating PMB ethers, commenting on the formation N-methyl-2-lepidone.
160
 
 
Scheme 13: Formation of PMB Ethers Using 2-(4-methoxybenzyloxy)-4-methylquinoline
 
 
Recently, the Kunishima group has developed triazinylammonium salts, more 
specifically 4-(4,6-diphenoxy-1,3,5-triazin-2-yl)-4-benzylmorpholinium 
trifluoromethanesulfonate (DPT-BM) 86, to install benzyl ethers at room temperature.
161
 
However, it should be noted that the Dudley, Paquette, and Kunishima reagents required the 
addition of MgO to function optimally as it acts as a mild base and desiccant for acid and/or trace 
amounts of water. Again, this reagent provides good yields for benzyl ether 73, which may 
undergo a facile retroaldol reaction under basic conditions. Also notable is the formation of 
17 
 
benzyl ether 75, as -silyl alcohols are sensitive to both acidic and basic etherification 
conditions. 
 
Scheme 14: Formation of Benzyl Ethers Using DPT-BM
 
 
 
1.5 Summary 
Although the literature contains expansive investigations towards O-alkylation using 
trichloroacetimidates and imidate-based reagents, prior to this work
86
 no known investigation 
reported sulfide formation using trichloroacetimidates without the addition of a Brønsted or 
Lewis acid catalyst. The work
79,86
 described in the subsequent chapters illustrates that 
trichloroacetimidates can alkylate both thiols and alcohols efficiently solely under thermal 
conditions, providing new ways to form ethers and sulfides and protect alcohols and thiols under 
mild conditions.  
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Chapter 2. Thioetherification Utilizing Trichloroacetimidates  
Under Thermal Conditions 
 
2.1 Introduction 
 
In addition to being of great medicinal and pharmaceutical importance (see Chapter 1, 
Figure 2),
1-11
 thioethers are commonly found in molecules with diverse structures and functions, 
including secondary metabolites,
4,12-16
 enzyme cofactors,
5,17
 and pesticides.
18,19
 Thioethers are 
also a the precursors to sulfoxides and sulfones, which are versatile synthons with numerous 
synthetic applications, including the Julia – Lythgoe olefination, the Ramberg – Bäcklund 
rearrangement, and the formation of unsaturated ketones from -thio ketones (Scheme 15).
20-31
  
 
Scheme 15: Selected Examples of Olefination Reactions Utilizing Sulfones and Sulfoxides 
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2.2 Common Methods for the Synthesis of Sulfides 
 
Due to their importance, the literature contains numerous methods to form sulfides from a 
variety of precursors.
 
The most stereotypical route towards thioether formation is via an SN2 
displacement of an alkyl halide and metal thiolate; however this requires a strong base and 
generates an inherent byproduct: an equimolar amount of metal halide.
32-39 
While still often 
employed, researchers often prefer to utilize more mild conditions to form sulfides.
 
The addition of thiols to alkenes has also been explored as a means to form sulfides. For 
example, asymmetric sulfa-Michael additions to electron-deficient alkenes with thiol 
nucleophiles are considered a reliable methodology for the synthesis of chiral thioethers; 
however this method usually requires chiral catalysts like thioureas,
43
 squaramides,
44
 or strongly 
basic guanidine derivatives.
45
 Substrates may also be limited as the carbonyl is required to 
activate the alkene for the addition reaction.
43-46
 A recent example of this type of methodology is 
the system of Luo and co-workers (Table 3). This reaction effects an efficient conjugate 
addition-protonation reaction of thiols to α-substituted vinyl ketones by a chiral primary amine 
catalyst 101 and TfOH.
46
  
44 
In addition to sulfa-Michael additions, thiols can also add to unactivated olefins in an 
anti-Markovnikov manner,
47-57
 commonly via the thiol-ene reaction.
47,53-57
 Initially reported by 
Posner in 1905,
47
 the thiol-ene reaction is widely applicable in polymer and synthetic chemistry. 
This reaction requires a photoinitiator, such as benzophenone or dimethyloxyphenyl 
acetophenone,
48-52
 or more recently, ruthenium polypyridyl complexes.
57
Scheme 16: General Mechanism of Radical Thiol-Ene Reaction 
The direct displacement of alcohols with thiols has also been explored. Commonly the 
Mitsunobu reaction may be employed, which is an effective method for the synthesis of sulfides 
Table 3: Selected Examples of Asymmetric Synthesis of Thioethers46
45 
from alcohols. Unfortunately this reaction generates large amounts of waste byproducts in the 
form of triphenylphosphine oxide and reduced azodicarboxylates byproducts, which limits its 
utility to small scale reactions.
40-42
Scheme 17: An Example of the Mitsunobu Reaction in the Synthesis of a Sulfide 
Other direct displacement reactions towards sulfides, generally employing acetates or 
alcohols as leaving groups for thiol nucleophiles, have been investigated to reduce the waste 
products generated in the Mitsunobu reaction. These reactions usually require a promoter like a 
Lewis or Brønsted acid or transition metal catalyst. In many cases these reactions proceed 
through SN1 type mechanisms, which limit the substrate scope.
39,58-88
One early example of thioether formation via alcohol displacement was reported by 
Kagan and co-workers. This work described thioether formation from a limited series of allylic 
alcohols and thiols in which they used SmCl3 as a catalyst
60 
The authors propose that the
displacement occurs via a stabilized allylic cation and hence looses any inherent stereochemical 
information present in the alcohol. Numerous groups have since investigated transition-metal 
catalyzed allylic substitution to form thioethers.
60,65-70,84-88
 While these systems perform well,
they are typically limited to allylic substrates. 
Scheme 18:  Selected Examples of Samarium (III) Trichloride Allylic Ether Formation 
46 
More recently, Hidai and Uemura have demonstrated the displacement of propargyl 
alcohols with thiols using a novel cationic methanethiolate-bridged diruthenium complex, 117. 
Complex 117 itself can be prepared by stirring AgOTf with [Cp*Ru(SMe)2RuCp*(OH2)], which 
is quite expensive and difficult to prepare. This displacement has been reported to generate the 
desired sulfide in the presence of a catalytic amount of a NH4BF4.
84
Additionally, Wu and co-workers recently disclosed that a catalytic amount of Ga(OTf)3 
can promote displacement of alcohols with sulfur nucleophiles.
64
 The yields of these processes 
are good to excellent depending on the substrates, although this method was limited to activated 
allylic and benzylic alcohols as it also proceeds by an SN1 mechanism.  
Scheme 19: Selected Examples of Gallium (III) Triflate Catalyzed Sulfide Formation 
Table 4: Selected Examples of Ruthenium-Catalyzed Propargylic Sulfides 
47 
2.3 Reaction Development 
Researchers in the Chisholm laboratory noted that trichloroacetimidate 19 would 
rearrange to the corresponding acetamide 133 when heated in refluxing solvent, usually toluene
89
(Scheme 20), without any added Brønsted or Lewis acid catalyst. The typical [3,3]-sigmatropic 
rearrangement that transforms allylic imidates to allylic acetamides
90 
is not available to imidate
19, so this rearrangement was unexpected.  
Scheme 20: Proposed Generation of the DPM Acetamide in Absence of Nucleophile 
Mechanistically, it was hypothesized that the imidate ionizes to form the stable 
diphenylmethyl cation 134 and, should no nucleophile be present, the trichloroacetamide anion 
(a weak base with a pKa of 11 in DMSO)
91
 adds and forms the corresponding trichloroacetamide
135. However, in the presence of a more effective external nucleophile like a thiol, it may be
possible to trap the cation, leading to the formation of sulfide 139 and trichloroacetamide 140 
without the use of an acid or base promoter, as seen in Scheme 21. This could provide a method 
to generate sulfides under essentially neutral conditions without a catalyst, where the strongest 
base present is the trichloroacetamide anion 133.  
48 
Scheme 21: Possible Mechanistic Pathway of Sulfide Generation 
Figure 6: Possible Concerted Transition State of Sulfide Generation 
 As described in Scheme 21, we suspect that the substitution reaction may occur through 
either an SN1 or SN2 pathway (stepwise proton transfer) or through a highly ordered six-
membered transition state (concerted proton transfer) where the C-O bond breaking and C-S 
bond formation are simultaneous as shown in Figure 6.  The reaction also may be dependent on 
the pKa of the thiol nucleophile (which may first protonate the imidate). The substitution would 
obviously proceed much more rapidly if protonation occurs first, activating the imidate before 
displacement and accelerating either an SN1 or SN2 pathway. To our knowledge, there have been 
no attempts at sulfide formation using trichloroacetimidates without the addition of a Brønsted or 
Lewis acid catalyst.
92,93 
In this report, we have investigated the scope of these
trichloroacetimidate displacements to generate sulfides. The rest of this chapter is focused on 
49 
investigations into the reactivity of alkyl, allylic/propargylic, electron-poor and electron–rich 
trichloroacetimidates with several thiols having different acidities.
94
All trichloroacetimidates discussed in this chapter were generated using typical reaction 
conditions for their formation, as shown in Scheme 3.
 
O - Diphenylmethyl (DPM) 
trichloroacetimidate 19 was used as an initial substrate since previous publications from the 
Chisholm laboratory
89
 have shown that this imidate is particularly reactive, and therefore may be
an excellent precursor for DPM sulfides. As DPM is a useful protecting group for thiols this 
reaction would have utility regardless of any other limitations to the substrate scope.
95
 Previous
experiments in the Chisholm laboratory defined the optimal conditions for etherification with the 
DPM trichloroacetimidate as refluxing in toluene solvent without a catalyst for 18 hours.
89
 As
such, these conditions were initially explored to generate the desired sulfide.
 
Refluxing DPM 
imidate 19 with thiol 145 in toluene provided sulfide 146 in 76% yield, confirming our 
hypothesis that thiols can be alkylated with trichloroacetimidates without an added catalyst or 
promoter (Table 5, Entry 1). As thiols are typically better nucleophiles than alcohols, lower 
reaction temperatures were explored to determine if the reaction could proceed under even more 
mild conditions. Lowering the reaction temperature to 23 °C provided no product, while 
performing the displacement at 65 °C gave a significantly decreased yield, indicating that an 
elevated temperature was necessary. A variety of solvents were screened, as seen in Table 1, and 
THF emerged as the optimal solvent, providing an 88% yield of product after refluxing the 
reactants for 18 h. THF proved to be a much better medium for the substitution, as even at room 
temperature 70% of sulfide 146 could be isolated after 18 h.  
50 
Table 5: Reaction of DPM trichloroacetimidate 19 with Thiol 143
a
Entry Solvent Temperature Yield
b
1 toluene 111 °C 76% 
2 toluene 23 °C 0 
3 toluene 65 °C 45% 
4 dichloromethane 40 °C 48% 
5 THF 23 °C 70% 
6 THF 66 °C 88% 
7 2-butanone 80 °C Trace 
8 acetonitrile 82 °C 52% 
9 DMF 100 °C 18% 
a
All reactions were performed at 0.1M for 18 h in the noted solvent. 
b
Isolated yields. 
A number of different thiol substrates were then explored to determine if they would 
participate in the imidate displacement. The initial hypothesis that the sulfide formation may be 
dependent on the pKa of the thiol was also tested by utilizing thiols with different acidities. The 
range of nucleophilic thiols were chosen with respect to the 2-mercaptobenzthiazole, which has a 
pKa of 1.4 in DMSO (Table 6).
96 
This investigation was performed in the context of evaluating
the installation of both the DPM and PMB protecting group, and so two imidates that may be 
used to install thiol protecting groups, diphenylmethyl trichloroacetimidate (19) and 4-
methoxybenzyl-2,2,2-trichloroacetimidate (16), were chosen as alkylation reagents.
97
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Table 6: Varying Nucleophile pKa
96
 with DPM (19) or PMB (16) imidate 
 
    
 
Generally, the yields of the thiol alkylation were higher with DPM imidate 19 than with 
PMB imidate 16, likely due to the enhanced electrophilicity of this reagent. The aromatic thiols 
investigated proved to be excellent substrates for this alkylation reaction, providing the sulfide in 
high yields. Alkyl thiols provided more moderate yields of the desired sulfide; we suspect the 
52 
 
lower acidity of these thiols leads to a slower proton transfer to the imidate nitrogen, resulting in 
a less rapid displacement of the imidate.  
Conveniently, when the reaction mixtures were washed with 2M aqueous NaOH solution 
to remove any unreacted thiol, it was noticed that the trichloroacetamide byproduct was also 
removed. Trichloroacetamide is insoluble in water, and aforementioned, has a pKa of 11.
91
 The 
deprotonated acetamide should be much more soluble in water, however, and therefore could be 
removed via the aqueous washing. This discovery provides a convenient purification method for 
the thioetherification and other alkylation reactions with trichloroacetimidates by the removal of 
the major byproduct, further enhancing the usefulness and applicability of this methodology. 
Variation of the trichloroacetimidate electrophile, the imidate alkylating reagent, was 
then explored. Experiments were performed in THF at reflux with 1-phenyl-1H-tetrazole-5-thiol 
123, as this thiol not only provided high yields, the reaction products may be transformed into 
sulfones that are useful for stereoselective Julia-Lythgoe olefination reactions.
 21-26
 Table 7 
depicts the reaction of benzylic trichloroacetimidates with thiol 123. The trichloroacetimidates 
varied from phenyl, methyl and hydrogen at the alpha position, and the yields did not vary 
greatly based on substitution, 94%, 87%, and 87% respectively. This demonstrates the versatility 
of trichloroacetimidates to generate sulfides as the substitution at the alpha position of the 
benzylic trichloroacetimidates does not affect the yield significantly. 
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Table 7: Reaction of Benzylic Imidates with Thiol 123 
 
 
 
 
 
Table 8 demonstrates that electron-withdrawing benzyl trichloroacetimidates are just as 
capable in generating sulfides as electron-donating ones. More specifically, the electron-rich 
PMB imidate 16 afforded alkylated thiol 126 in 84% yield while the electron-poor imidate 167 
provided alkylated thiol 168 in 72% yield. The high reactivity with these groups supports the 
hypothesis that the reaction may proceed through the SN2 pathway, although Friedel Crafts 
reactions of similar electron poor imidates have been observed under Lewis-acid mediated 
conditions at high temperature.
97
 Another possibility is that the reaction may proceed under 
either an SN1 or an SN2 pathway depending on the structure of the trichloroacetimidate. 
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Table 8: Reaction of Benzylic Imidates with Thiol 123 
 
 
 
 
Tables 9 and 10 show that allylic and propargylic trichloroacetimidates have improved 
reactivity with thiol 123 when compared to benzylic trichloroacetimidates. No products of SN2’ 
55 
 
addition was observed with the allylic and propargylic imidates. The highest yielding reaction 
used prenyl imidate 171 which afforded alkylated thiol 172 in 98% yield, Entry 2. 
Table 9: Reaction of Allylic and Propargylic Imidates with Thiol 123 
 
 
 
 
Table 10 further illustrates the versatility of trichloroacetimidates to generate sulfides as 
observed with geraniol trichloroacetimidate, 175, and nerol trichloroacetimidate, 177, as no 
apparent isomerization of the trisubstituted alkene geometry occurred and the sulfide products 
were isolated in 83% and 88% yield, respectively. No isomerization of the trisubstituted alkenes 
seems to implicate an SN2 mechanism in these cases, as the formation of an allylic cation (which 
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occur in an SN1 process) may lead to isomerization of the alkene. The phthalimidomethyl system 
also proved capable in generating the desired sulfide 181 in 78% yield (Table 10, Entry 4). 
Table 10: Reaction of Allylic and Propargylic Imidates with Thiol 123 
 
 
 
 
 
 Thiol additions to alkyl trichloroacetimidates were also investigated (Table 11). 
Unhindered methyl and ethyl trichloroacetimidates provided the corresponding sulfides in 
moderate yields, 75% and 81%, respectively. No reaction was observed with the isopropyl 
imidate 186 in refluxing THF, but switching to the higher-boiling toluene as the solvent yielded 
the desired product in a moderate yield of 38%. The yield of 187 could be increased to 51% by 
using 5 equivalents of the imidate. Reaction of thiol 123 with tert-butyl imidate did not provide 
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the desired sulfide product, however, but yielded the tetrazolothione 189 as the major product 
instead in 32% yield. The yield could be increased to 55% by using 5 equivalents of imidate. We 
suspect that steric interaction between the bulky tert-butyl group and the adjacent N-phenyl ring 
on thiol 123 may favor alkylation of the nitrogen, leading to the tetrazolothione. Recently Wu 
and co-workers found sulfides could be rearranged to the tetrazolothione thermodynamically by 
heating in DCE with catalytic Ga(OTf)3,
64
 so it is possible that after initial S-alkylation the tert-
butyl migrates to generate the tetrazolothione. Given that both methyl and tert-butyl imidates 
react under these conditions, both an SN1 or SN2 mechanism is available to this reaction; 
however, as yields are higher with primary imidates, an SN2 pathway seems preferred.  
Table 11: Reaction of Thiol 123 with Alkyl Imidates 
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While addition of the thiol to the trichloroacetimidate provides a powerful method for the 
formation of new sulfides under near neutral conditions, one must still prepare the 
trichloroacetimidate from the alcohol before substitution, as seen in Scheme 3. Attempts were 
therefore made to streamline the process into a one-pot procedure by forming the 
trichloroacetimidate in situ. In situ formation of the imidate has been used to form allylic 
trichloroacetimidates for use in the Overman rearrangement,
90
 and similar procedures have been 
used for substitution reactions in some isatin derivatives.
92
 Alcohols were first subjected to 
imidate formation conditions in anhydrous THF followed by addition of the thiol and simple 
heating. This procedure has provided the sulfides without the need for isolation of the 
trichloroacetimidate intermediate further streamlining this methodology. Table 12 depicts the 
generation of benzylic sulfides in respectable yields from the commercially available alcohols, 1-
phenylethanol and benzyl alcohol, 64% and 78%, respectively.  
 
Table 12: One-pot Conversion of Benzylic Alcohols to Sulfides  
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Table 13 illustrates the versatility of this one-pot process as multiple allylic examples 
were completed in addition to one alkyl example, 1-butanol. All yields are slightly lower than the 
displacement with purified imidate (which is to be expected as two reactions are being 
performed) with prenyl alcohol being the highest yielding, 82%.  
Table 13: One-pot Conversion of Alcohols to Sulfides 
 
 
 
We hypothesized the moderate yield of the isopropyl sulfide generation in Table 11, entry 
3, may be due to competing elimination reactions to form the volatile alkene as a side product, as 
the substitution reaction may be sluggish due to sterics. The alkene formed in this case would be 
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a gas, however, so it would be difficult to prove this hypothesis. To further explore this idea, we 
subjected β-dihydrocholesterol 198 with thiol 123 to the in situ substitution conditions. Any 
alkenes formed from the reaction should be isolable in the higher molecular weight steroid 
skeleton. In addition, this would provide some evidence of the mechanistic pathway, as the 
stereocenter on the steroid will provide information on the displacement proceeding with 
retention or inversion. 
 Exposing steroid 198 to in situ substitution conditions in refluxing THF did not yield 
product, and starting thiol 123 and the steroidal imidate were recovered from the reaction. This 
result is consistent with the reaction of isopropyl trichloroacetimidate, which required heating the 
reaction in toluene to generate the desired sulfide 187. Formation of steroid imidate in toluene 
followed by addition of thiol led to generation of desired sulfide 199 in 44% yield. None of the 
β-isomer was observed in the crude 
1
H NMR, with the remaining material being unreacted 
imidate, 24% yield, and a mixture of alkenes in 30% yield. This process was also completed in a 
two-pot method, which yielded similar results in both yield and of materials. 
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 Scheme 22: One-pot Conversion of β-dihydrocholesterol to α-sulfide 
 
 The low yield of the displacement may be due to the thiol having to attack from an axial 
position and therefore it must negotiate the axial hydrogens at C1 and C5 of the steroid, so it was 
theorized that the opposite alcohol diastereomer may be a better substrate for displacement. To 
investigate this possibility, steroid imidate 204 was generated by subjecting alcohol 199 to 
Mitsunobu conditions followed by hydrolysis of the benzoate to generate the corresponding -
alcohol 203 (Scheme 23).  
 
Scheme 23: Generation of α –dihydrocholesterol 
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-Alcohol 203 was used to generate the corresponding imidate 204 and subjected to the 
two-pot method, as shown in Scheme 29. Addition of thiol 123 in refluxing toluene led to 
generation of desired sulfide 205 in 48% yield. None of the α-isomer was observed in the crude 
1
H NMR, with the remaining material being unreacted imidate, 25% yield, and a mixture of 
alkenes in 26% yield. The moderate yield of these displacements is therefore most likely due to 
the unreactive nature of the secondary imidate, and not due to any steric factors derived from the 
steroid core. As complete inversion was observed with no retention product, these reactions must 
proceed through an SN2 manifold.  
 
Scheme 24: Conversion of α-dihydrocholesterol to β-sulfide 
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2.4 Summary 
  
 In summary, we have developed a new method
94
 of alkylating thiols under thermal 
conditions without the need of an acid, base, or transition metal catalyst by utilizing a 
trichloroacetimidate as an electrophile. Using thiols as substrates, we have shown that the 
reaction tolerates considerable variation of nucleophiles. In addition, we have shown the 
versatility of the trichloroacetimidate electrophile with alkyl, allylic/propargylic, and benzylic 
trichloroacetimidates with both electron-donating and –withdrawing groups providing good 
yields with 1-phenyl-1H-tetrazole-5-thiol, 123.  
We propose that this displacement precedes either by SN2 or SN1 pathway depending on 
the nature of the electrophile. Support for an SN2 pathway was found with the generation of 
chiral steroid alcohols 198 and 203 proceeding solely to the respective inverted sulfide. 
Additionally, support for SN2 preference is apparent as yields are higher with methyl and primary 
alkyl imidates and no isomerization of the trisubstituted alkene geometry of geraniol 175 and 
nerol 177 imidates. Support for an SN1 pathway comes from the ability to generate sulfide 145 
from DPM imidate, as previous work
89
 has shown that addition to this substrate typically 
proceeds through an SN1 manifold, and the ability for tert-butyl imidate to react, as this is strictly 
limited to an SN1 pathway. 
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2.5 Experimental 
 
 
General Methods: All anhydrous reactions were run under a positive pressure of argon or 
nitrogen. All syringes, needles, and reaction flasks required for anhydrous reactions were dried in 
an oven and cooled under an N2 atmosphere or in a desiccator. Dichloromethane and THF were 
dried by passage through an alumina column following the method of Grubbs (Pangborn, A. B.; 
Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518). 
Triethylamine was distilled from CaH2. All other reagents and solvents were purchased from 
commercial sources and used without further purification.  
Analysis and Purification. Analytical thin layer chromatography (TLC) was performed on 
precoated glass backed plates (silica gel 60 F254; 0.25 mm thickness). The TLC plates were 
visualized by UV illumination and by staining. Solvents for chromatography are listed as 
volume:volume ratios. Flash column chromatography was carried out on silica gel (40-63 μm). 
Melting points were recorded using an electrothermal melting point apparatus and are 
uncorrected. Elemental analyses were performed on an elemental combustion system ECS 4010 
analyzer with a thermal conductivity detector and 2 meter GC column maintained at 50 °C. 
Identity. Proton (
1
H NMR) and carbon (
13
C NMR) nuclear magnetic resonance spectra were 
recorded at 300 or 400 MHz and 75 or 100 MHz respectively. The chemical shifts are given in 
parts per million (ppm) on the delta (δ) scale. Coupling constants are reported in hertz (Hz). The 
spectra were recorded in solutions of deuterated chloroform (CDCl3), with residual chloroform (δ 
7.26 ppm for 
1
H NMR, δ 77.23 ppm for 
13
C NMR) or tetramethylsilane (δ 0.00 for 
1
H NMR, δ 
0.00 ppm for 
13
C NMR) as the internal reference. Data are reported as follows: (s = singlet; d = 
doublet; t = triplet; q = quartet; p = pentet; dd = doublet of doublets; dt = doublet of triplets; td = 
triplet of doublets; tt = triplet of triplets; qd = quartet of doublets; ddd = doublet of doublet of 
65 
 
doublets; br s = broad singlet). Where applicable, the number of protons attached to the 
corresponding carbon atom was determined by DEPT 135 NMR. Infrared (IR) spectra were 
obtained as thin films on NaCl plates by dissolving the compound in CH2Cl2 followed by 
evaporation or as KBr pellets. 
 
1) General Procedure for Preparing Trichloroacetimidates: 
Benzhydrol (10.125 g, 54.9 mmol) was added to a 250 mL flame dried round-bottom flask. 55 
mL of dry DCM was added to dissolve the alcohol while under an argon atmosphere. 1,8-
diazabicyclo[5.4.0]undec-7-ene (0.83 mL, 5.5 mmol) and trichloroacetonitrile (6.1 mL, 82.4 
mmol) were then added to the reaction. This reaction mixture was allowed to stir for 20 hours at 
room temperature. The reaction mixture was concentrated under reduced pressure then pre-
adsorbed on silica gel, and purified by silica gel column chromatography using 20% ethyl 
acetate/ 75% hexanes/ 5% triethylamine. This provided desired trichloroacetimidate as a white 
solid (9.99 g, 56%). 
 
2) General Procedure for Generating Sulfides: 
1-phenyl-1H-tetrazole-5-thiol (0.203 g, 1.14 mmol) was placed into a 25 mL flame dried round-
bottom flask and was dissolved in 6 mL of dry THF. Diphenyl-methyl trichloroacetimidate (0.44 
g, 1.35 mmol) was added to the stirring reaction flask. The reaction mixture was heated to reflux 
while under an argon atmosphere for 18 hours. The reaction mixture was allowed to cool to room 
temperature, and was concentrated under reduced pressure. This was then pre-adsorbed on silica 
gel and purified by column chromatography using 30% ethyl acetate /70% hexanes. This 
provided desired sulfide as a white colored solid (0.127g, 94%). 
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3) General One-pot Conversion Procedure: 
Propargyl Alcohol (0.08 g, 1.43 mmol) was placed into a 25 mL flame dried round-bottom flask 
and was dissolved in 6 mL of dry THF. 1,8-diazabicyclo[5.4.0]undec-7-ene (122 µL, 0.82 mmol)  
and trichloroacetonitrile (1.23 mL, 12.3 mmol) were then added to the reaction. This reaction 
mixture was allowed to stir for 6 hours at room temperature. 1-phenyl-1H-tetrazole-5-thiol 
(0.203 g, 1.14 mmol) was added and the reaction mixture was heated to reflux while under an 
argon atmosphere for 18 hours. The reaction mixture was allowed to cool to room temperature, 
and was concentrated under reduced pressure, pre-adsorbed on silica gel, and purified by column 
chromatography using 20% ethyl acetate/ 80% hexanes. This provided desired sulfide as a brown 
colored solid (0.190 g, 77%). 
 
General Procedures for the Purification of Sulfides: 
Method A. The reaction mixture was pre-adsorbed on silica gel and purified by silica gel  
chromatography using the listed solvent system.  
Method B. The reaction mixture was cooled to room temperature, concentrated under reduced 
pressure and dissolved in 50 mL of ethyl acetate. The organic layer was washed five times with 
25 mL of 2M NaOH and then with 25 mL of brine. The organic layer was dried over anhydrous 
sodium sulfate and concentrated under reduced pressure to provide the desired sulfide. 
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5-[(Diphenylmethyl)thio]-1-phenyl-1H-Tetrazole (145). Prepared by General Procedure 2 
from the known imidate.
95
 Purified by Method A (30% ethyl acetate /70% hexanes solvent 
system).  White colored solid (0.127g, 94%). mp = 104.5-105.7°C; TLC Rf  = 0.45 (30% ethyl 
acetate /70% hexanes); IR (neat) 3061, 3029, 2927 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.58-
7.41 (m, 10H), 7.38-7.21 (m, 5H), 3.40 (s, 1H); 
13
C NMR (100 MHz, CDCl3) δ 152.9, 139.0, 
133.4, 130.0, 129.6, 128.6, 128.3, 127.8, 123.9, 56.4. Anal. calcd for C20H16N4S: C, 67.74; H, 
4.68; N, 16.27. Found: C, 69.99; H, 4.50; N, 16.00. 
 
2-[(Diphenylmethyl)thio]-benzothiazole (144). Prepared by General procedure 2 from the 
known imidate.
95
 Purified by Method A (10% acetone /90% hexanes solvent system). Cream 
colored solid (0.290 g, 88%). mp = 129.5-131°C; TLC Rf  = 0.44 (10% acetone /90% hexanes); 
IR (neat) 3059, 3026, 2923 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 1.6 Hz, 1H), 7.71 (d, 
J = 1.6 Hz, 1H), 7.48-7.36 (m, 2H), 7.45-7.25 (m, 10H), 6.30 (s, 1H), 1.56 (br s, 1H). 
13
C NMR 
(100 MHz, CDCl3): δ 165.5, 152.9, 139.8, 135.4, 128.7, 128.5, 127.7, 126.0, 124.3, 121.8, 120.9, 
56.3. Anal. calcd for C20H15NS2: C, 72.03; H, 4.53; N, 4.20. Found: C, 72.06; H, 4.39; N, 4.15.  
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5-((4-Methoxybenzyl)thio)-1-phenyl-1H-tetrazole (126).
64
 Prepared by General Procedure 2 
from the commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
Purified by Method 
A (30% ethyl acetate /70% hexanes solvent system). Cream colored solid (0.286 g, 89%). TLC 
Rf  = 0.42 (30% ethyl acetate /70% hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.48-7.36 (m, 5H), 
7.34 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 4.58 (s, 2H), 3.78 (s, 3H); 
13
C NMR (75 MHz, 
CDCl3) δ 159.5, 154.1, 133.6, 130.5, 130.1, 129.8, 127.1, 123.8, 114.2, 55.3, 37.3. 
 
2-[[(4-Methoxyphenyl)methyl]thio]-benzothiazole (146).
64
 Prepared by General Procedure 2 
from the commercially available 4-methoxybezyl-2,2,2 -trichloroacetimidate.
 
Purified by Method 
A (20% acetone /80% hexanes solvent system). Yellow colored solid (0.291 g, 89%). TLC Rf  = 
0.55 (20% acetone /80% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 1.2 Hz, 1H), 7.71 
(d, J = 2.0 Hz, 1H), 7.48-7.36 (m, 2H), 6.86 (d, J = 2.4 Hz, 2H), 4.58 (s, 2H), 3.78 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3) δ 163.8, 159.4, 153.9, 133.5, 130.4, 129.9, 129.6, 126.9, 123.6, 114.1, 
55.2, 53.2, 37.2.  
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2-[(Diphenylmethyl)thio]-pyridine (148). Prepared by General Procedure 2 from the known 
imidate.
95
 Purified by Method A (10% ethyl acetate/90% hexanes solvent system). White colored 
solid (0.269 g, 85%). TLC Rf  = 0.38 (10% ethyl acetate/90% hexanes).
 
mp = 66.4-67.3°C;  
IR (neat) 3060, 3027, 2961, 2923, 1600, 1576 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 8.38 (m, 1H), 
7.50-7.08 (m, 12 H), 6.97 (m, 1H), 6.41 (s, 1H); 
13
C NMR (100 MHz, CDCl3) δ 158.3, 149.4, 
141.3, 136.1, 128.5, 127.5, 127.0, 122.3, 119.8, 52.6. Anal. calcd for C18H15NS: C, 77.94; H, 
5.45; N, 5.05. Found: C, 78.24; H, 5.49; N, 4.90.
 
 
2-[[(4-Methoxyphenyl)methyl]thio]-pyridine (149).
64 
Prepared by General Procedure 2 from 
the commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
  
Purified by Method A 
(5% acetone /95% hexanes solvent system). Cream colored solid (0.214 g, 81%). TLC Rf  = 0.32 
(5% acetone /95% hexanes); 
1
H NMR (300 MHz, CDCl3) δ 8.42 – 8.41 (m, 1H), 7.41 (m, 3H), 
7.28 (d, J = 8.7 Hz, 2H), 7.11 (d, J = 7.5 Hz, 1H), 6.83-6.80 (m, 1H), 6.78 (d, J = 8.7 Hz, 2H), 
4.37 (s, 2H), 3.71 (s, 3H); 
13
C NMR (75 MHz, CDCl3): δ 159.1, 158.8, 149.4, 135.9, 130.1, 
129.9, 122.1, 119.6, 113.9, 55.3, 33.9. 
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1,1'-[(Phenylthio)methylene]bis-benzene (151). Prepared by General Procedure 2 from the 
known imidate.
95
 Purified by Method A (30% DCM /70% hexanes solvent system). White 
colored solid (0.127 g, 94%). mp = 61.8-63.4°C; TLC Rf  = 0.45 (30% DCM /70% hexanes);  
IR (neat) 3060, 3027, 3004, 2961, 2923, 1599 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.48-7.13 (m, 
15H), 5.54 (s, 1H); 
13
C NMR (75 MHz, CDCl3) δ 141.0, 136.1, 130.5, 129.1, 128.7, 128.5, 
127.5, 127.2, 127.2, 126.6, 57.4. Anal. calcd for C19H16S: C, 82.56; H, 5.83. Found: C, 82.62; H, 
5.58. 
 
1-Methoxy-4-[(phenylthio)methyl]-benzene (152).
 
Prepared by General Procedure 2 from the 
commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
Purified by Method A (30% 
DCM /70% hexanes solvent system). Cream colored solid (0.208 g, 79%). TLC Rf  = 0.44 (20% 
acetone /80% hexanes); mp = 76.1-77.8°C; IR (neat) 3047, 3003, 2959, 2912, 2837, 1250 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.31-7.19 (m, 6H), 6.82 (d, J = 8.8 Hz, 2H), 4.08 (s, 2H), 3.79 (s, 
3H). 
13
C NMR (100 MHz, CDCl3) δ 158.7, 136.5, 129.9, 129.8, 128.8, 126.2, 113.8, 113.8, 55.2, 
38.4. Anal. calcd for C14H14OS: C, 73.01; H, 6.13. Found: C, 72.97; H, 6.07.
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1-Bromo-2-[(diphenylmethyl)thio]-benzene (154). Prepared by General Procedure 2 from the 
known imidate.
 95
 Purified by Method A (30% DCM /70% hexanes solvent system). Yellow 
colored oil (0.343 g, 85%). TLC Rf  = 0.81, 0.71 (30% DCM /70% hexanes); IR (neat) 3084, 
3061, 3027, 2961, 650 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.50-6.91 (m, 14 H), 5.66 (s, 1H); 
13
C NMR (100 MHz, CDCl3) δ 140.0, 137.4, 132.8, 130.2, 129.6, 128.5, 128.4, 127.5, 126.9, 
124.1, 55.9. Anal. calcd for C19H15BrS: C, 64.23; H, 4.26. Found: C, 64.52; H, 4.45. 
 
1-Bromo-2-[1-methoxy-4-(phenylthio)methyl]-benzene (155). Prepared by General Procedure 
2 from the commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
Purified by 
Method A (20% acetone /80% hexanes solvent system). Cream colored solid (0.208 g, 59%).  
mp = 121.2-122.7°C; TLC Rf  = 0.44 (20% acetone /80% hexanes); IR (neat) 3074, 3033, 3003, 
2957, 1249 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 8.4 Hz, 2H), 7.51-7.21 (m, 3H), 
7.04-6.84 (m, 1H), 6.84 (d, J = 8.8 Hz, 2H), 4.11 (s, 2H), 3.79 (s, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 158.9, 138.1, 132.9, 130.1, 128.8, 127.9, 127.7, 126.8, 123.6, 114.0, 55.3, 37.4. Anal. 
calcd for C14H13BrOS: C, 54.38; H, 4.24. Found: C, 54.21; H, 4.22.  
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Methyl 2-(benzhydrylthio)acetate (157). Prepared by General Procedure 2 from the known 
imidate.
95
 Purified by Method B. Yellow colored oil (0.202 g, 65%). TLC Rf  = 0.46 (10% ethyl 
acetate/90% hexanes); IR (neat) 3084, 3060, 3027, 3003, 2950, 2843, 1735; 
1
H NMR (300 MHz, 
CDCl3) δ 7.44-7.22 (m, 10H), 5.39 (s, 1H), 3.65 (s, 3H), 3.08 (s, 2H); 
13
C NMR (75 MHz, 
CDCl3): δ 170.7, 140.3, 128.6, 128.4, 127.4, 54.2, 52.3, 33.5; Anal. calcd for C16H16O2S: C, 
70.56; H, 5.92. Found: C, 70.55; H, 5.92. 
 
Methyl 2-((4-methoxybenzyl)thio)acetate (158). Prepared by General Procedure 2 from the 
commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
Purified by Method B. 
Yellow colored oil (0.132 g, 51%). TLC Rf  = 0.34 (10% ethyl acetate/90% hexanes);  
IR (neat) 3030, 3000, 2952, 2836, 1744; 
1
H NMR (300 MHz, CDCl3) δ 7.25 (d, J = 6.3 Hz, 2H), 
6.85 (d, J = 6.6 Hz, 2H), 3.79-3.78 (m, 5H), 3.72 (s, 3H), 3.07 (s, 2H); 
13
C NMR (75 MHz, 
CDCl3) δ 170.9, 158.8, 130.3, 129.1, 113.9, 55.3, 52.3, 35.8, 31.9; Anal. calcd for C11H14O3S: C, 
58.38; H, 6.24. Found: C, 58.30; H, 6.28.  
 
 
 
 
73 
 
 
Benzhydryl dodecyl sulfide (160).
100
 Prepared by General Procedure 2 from the known 
imidate.
95 
 Purified by Method A (30% DCM /70% hexanes solvent system). Colorless oil (0.273 
g, 64%). TLC Rf  = 0.57 (30% DCM/70% hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.43-7.18 (m, 
10H), 5.14 (s, 1H), 2.37 (t, 2H, J = 5.7 Hz), 1.58-1.49 (m, 2H), 1.32-1.23 (m, 12H), 0.88 (t, 3H, 
J = 5.1 Hz); 
13
C NMR (75 MHz, CDCl3) δ 142.2, 141.6, 129.3, 128.6, 127.4, 54.1, 32.3, 31.9, 
29.6, 29.5, 29.4, 29.3, 29.1, 28.9, 28.8, 22.7, 14.1.
 
 
Dodecyl 4-methoxybenzyl sulfide (161).
100 
Prepared by General Procedure 2 from the 
commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
Purified by Method A (20% 
DCM /80% hexanes solvent system). Colorless oil (0.149 g, 40%). TLC Rf  = 0.38 (20% DCM 
/80% hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.22 (d, J = 6.6 Hz, 2H), 6.84 (d, J = 6.6 Hz, 2H), 
3.80 (s, 3H), 3.66 (s, 2H), 2.40 (t, J = 5.7 Hz, 2H), 1.56-1.49 (m, 2H), 1.31-1.23 (m, 12H), 0.88 
(t, J = 5.1 Hz, 3H); 
13
C NMR (75 MHz, CDCl3): δ 158.5, 130.7, 129.8, 113.8, 55.3, 35.6, 31.9, 
31.3, 29.7, 29.6, 29.59, 29.5, 29.3, 29.2, 28.9, 22.7, 14.1. 
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5-(Benzylthio)-1-phenyl-1H-tetrazole (124).
64 
Prepared by General Procedures 2 and 3 from 
the commercially available benzyl alcohol or benzyl-2,2,2-trichloroacetimidate.
 
 Purified by 
Method A (30% ethyl acetate /70% hexanes solvent system). Cream colored solid (0.193g, 87%). 
mp = 68.8-69.7°C (ethyl acetate), lit = 69-70°C; TLC Rf  = 0.55 (30% ethyl acetate /70% 
hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.58-7.50 (m, 5H), 7.45-7.22 (m, 5H), 4.62 (s, 1H); 
13
C 
NMR (100 MHz, CDCl3) δ 153.8, 135.2, 133.6, 130.1, 129.7, 129.2, 128.8, 128.2, 123.8, 37.6.  
 
1-Phenyl-5-[(1-phenylethyl)thio]-1H-tetrazole (163).
64
 Prepared by General Procedure 2 from 
the known imidate.
102 
 Purified by Method A (30% ethyl acetate /70% hexanes solvent system). 
Yellow colored oil (0.141 g, 87%). TLC Rf  = 0.65 (30% ethyl acetate /70% hexanes); 
1
H NMR 
(300 MHz, CDCl3) δ 7.54-7.49 (m, 5H), 5.29 (q, J = 7.2 Hz, 1H), 1.88 (d, J = 6.9 Hz, 3H); 
13
C 
NMR (75 MHz, CDCl3) δ 153.5, 140.7, 133.4, 129.9, 129.5, 128.6, 128.0, 127.1, 123.8, 47.8, 
22.1. 
 
5-[[(4-Chlorophenyl)methyl]thio]-1-phenyl-1H-tetrazole (125).
64
 Prepared by General 
Procedure 2 from the known imidate.
 99
 Purified by Method A (20% ethyl acetate /80% hexanes 
solvent system). White colored solid (0.271 g, 88%). mp = 102-104°C; TLC Rf  = 0.368 (20% 
ethyl acetate /80% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.61-7.55 (m, 5H), 7.39-1.36 (m, 
75 
 
2H), 7.30-7.26 (m, 2H), 4.58 (s, 2H); 
13
C NMR (100 MHz, CDCl3) δ 153.3, 133.8, 133.7, 133.2, 
130.3, 129.9, 129.5, 128.7, 123.5, 36.5. 
 
3-Nitrobenzyl 2,2,2-trichloroacetimidate (165). Prepared by General Procedure 1. Purified by 
Method A (20% ethyl acetate/ 75% hexanes/ 5% triethylamine solvent system). Light orange 
colored solid (2.19 g, 90%). TLC Rf  = 0.50 (20% ethyl acetate/ 75% hexanes/ 5% triethylamine). 
mp = 32.4-32.9°C; IR (neat) 3340, 3090, 3077, 1646, 1530, 1352 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 8.51 (br s, 1H), 8.33 (s, 1H), 8.20 (d, J = 9.2 Hz, 1H), 7.79 (d, J = 8.0 Hz, 1H), 7.58 (t, 
J = 8.0 Hz, 1H), 5.44 (s, 2H); 
13
C NMR (100 MHz, CDCl3) δ 162.1, 148.4, 137.5, 133.5, 129.6, 
123.2, 122.5, 90.9, 69.0; Anal. calcd for C9H7Cl3N2O3: C, 36.33; H, 2.37; N, 9.42. Found: C, 
36.25; H, 2.22; N, 9.18. 
 
5-[[(3-Nitrophenyl)methyl]thio]-1-phenyl-1H-tetrazole (166).  Prepared by General Procedure 
2 from the prepared imidate 84.
 
Purified by Method A (50% DCM /50% hexanes solvent 
system). White colored solid (0.247 g, 80%). TLC Rf  = 0.36 (50% DCM /50% hexanes); mp = 
119.8-120.9°C; IR (neat) 3091, 3077, 3059, 2996, 1527, 1353 cm
-1
; 
1
H NMR (300 MHz, CDCl3) 
δ 8.32-8.31 (m, 1H), 8.16 (d, J = 8.1 Hz, 1H), 7.87 (d, J = 8.1 Hz, 1H), 7.58-7.49 (m, 5H), 7.28-
7.15 (m, 2H), 4.69 (s, 2H); 
13
C NMR (75 MHz, CDCl3) δ 153.0, 148.4, 137.8, 135.4, 133.4, 
130.3, 129.9, 129.7, 124.1, 123.7, 123.1, 36.3. Anal. calcd for C14H11N5O2S: C, 53.66; H, 3.54; 
N, 22.35. Found: C, 53.55; H, 3.67; N, 22.37. 
76 
 
 
 
4-[[(1-Phenyl-1H-tetrazol-5-yl)thio]methyl]-benzonitrile (168). Prepared by General 
Procedure 2 from the known imidate.
102 
 Purified by Method A (20% ethyl acetate /80% hexanes 
solvent system). Cream  colored solid (0.298 g, 72%). TLC Rf  = 0.24 (20% ethyl acetate /80% 
hexanes); mp = 102.8-104.1°C; IR (neat) 2956, 2925, 2854, 2229 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 7.61-7.49 (m, 10H), 4.63 (s, 2H);
 13
C NMR (75 MHz, CDCl3) δ 153.1, 141.1, 133.3, 
132.5, 130.3, 129.8, 129.2, 123.9, 118.4, 111.9, 36.6. Anal. calcd for C15H11N5S: C, 61.42; H, 
3.78; N, 23.87. Found: C, 61.68; H, 3.68; N, 23.48. 
 
Furfuryl 2,2,2-trichloroacetimidate (169). Prepared by General Procedure 1. Purified by 
Method A (20% ethyl acetate/ 75% hexanes/ 5% triethylamine solvent system). Yellow colored 
oil (1.98 g, 99%). TLC Rf  = 0.75 (20% ethyl acetate/ 75% hexanes/ 5% triethylamine);
1
H NMR 
(400 MHz, CDCl3) δ 8.42 (br s, 1H), 7.45 (s, 1H), 6.49 (m, 1H), 6.38 (m, 1H), 5.29 (s, 2H); 
13
C 
NMR (75 MHz, CDCl3) δ 162.1, 148.6, 143.3, 111.1, 110.4, 91.1, 62.5; Anal. calcd for 
C7H6Cl3NO3: C, 34.67; H, 2.49; N, 5.78. Found: C, 34.72; H, 2.42; N, 5.85. 
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5-[(2-Furanylmethyl)thio]-1-phenyl-1H-tetrazole (127).
64 
 Prepared by General Procedures 2 
and 3 from the commercially available alcohol or prepared imidate.
 
 Purified by Method A (20% 
acetone /80% hexanes solvent system). Yellow colored oil (0.332 g, 69%). TLC Rf  = 0.42 (20% 
acetone /80% hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.96 – 7.94 (m, 2H), 7.58-7.51 (m, 5H), 
7.36 (s, 1H), 6.61 (d, J = 3.0 Hz, 1H), 6.39 (d, J = 3.9 Hz, 2H), 4.24 (s, 2H); 
13
C NMR (75 MHz, 
CDCl3) δ 153.5, 148.3, 142.9, 133.5, 130.2, 129.8, 123.8, 110.8, 109.8, 30.1.  
 
1-Phenyl-5-(2-propen-1-ylthio)-1H-tetrazole (170).
88
 Prepared by General Procedure 2 from 
the commercially available O-allyl 2,2,2-trichloroacetimidate.
 
 Purified by Method A (20% ethyl 
acetate /80% hexanes solvent system). Yellow colored oil (0.201 g, 81%). TLC Rf  = 0.60 (30% 
ethyl acetate /70% hexanes); IR (neat) 3069, 3010, 2981, 2928 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 7.61-7.55 (m, 5H), 6.08-5.87 (m, 1H), 5.39 (d, J = 2.4 Hz, 1H), 5.17 (d, J = 1.2 Hz, 
1H), 4.01 (d, J = 9.0 Hz, 2H);
 13
C NMR (75 MHz, CDCl3) δ 153.6, 133.4, 131.3, 130.0, 129.6, 
123.7, 119.9, 35.7.  
 
5-[(3-Methyl-2-butenyl)thio]-1-phenyl-1H-tetrazole (172). Prepared by General Procedures 2 
and 3 from the commercially available alcohol or known imidate.
 98
 Purified by Method A (30% 
ethyl acetate /70% hexanes solvent system). Cream colored solid (0.250 g, 98%). mp = 38-39°C; 
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TLC Rf  = 0.72 (30% ethyl acetate /70% hexanes); IR (neat) 3062, 3015, 2981, 2928, 2895 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.61-7.55 (m, 5H), 5.44-7.37 (m, 1H), 4.04 (d, J = 8.0 Hz, 2H), 
1.73 (s, 6H);
 13
C NMR (75 MHz, CDCl3) δ 154.3, 139.8, 133.7, 129.9, 129.7, 123.7, 116.8, 31.6, 
25.6, 17.9. Anal calcd for C12H14N4S: C, 58.51; H, 5.73, N, 22.74. Found: C, 58.29; H, 5.54; N, 
22.39.  
 
1-Phenyl-5-[[(2E)-3-phenyl-2-propen-1-yl]thio]-1H-tetrazole (130).
64
 Prepared by General 
Procedure 2 from the known imidate.
103 
 Purified by Method A (30% ethyl acetate /70% hexanes 
solvent system). Yellow colored oil (0.264 g, 95%). TLC Rf  = 0.63 (30% ethyl acetate /70% 
hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.61-7.55 (m, 5H), 7.39-7.27 (m, 5H), 6.72 (d, J = 15.6 
Hz, 1H), 6.41-6.31 (m, 1H), 4.23 (d, J = 8.8 Hz, 2H); 
13
C NMR (100 MHz, CDCl3) δ 153.6, 
135.7, 134.9, 133.3, 129.9, 129.6, 129.5, 128.4, 128.3, 127.9, 126.3, 123.6, 122.2, 35.6.  
 
2-Cyclohexen-1-yl-1-phenyl-1H-tetrazole-5-thiol (132).
64 
Prepared by General Procedure 2 
from the known imidate.
104 
 Purified by Method A (20% ethyl acetate /80% hexanes solvent 
system). Yellow colored oil (0.104 g, 91%). TLC Rf  = 0.65 (20% ethyl acetate /80% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.61-7.55 (m, 5H), 6.01-5.78 (m, 2H), 4.78-4.72 (m, 1H), 2.24-
1.67 (m, 6H); 
13
C NMR (100 MHz, CDCl3) δ 154.1, 133.0, 129.9, 129.7, 124.8, 123.8, 44.7, 
28.9, 24.8, 19.1. 
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 (E)-[(3,7-Dimethyl-2,6-octadienyl)thio]-1-phenyl-1H-tetrazole (176).
88
 Prepared by General 
Procedures 2 and 3 from the commercially available alcohol or known imidate.
 104
 Purified by 
Method A (30% ethyl acetate /70% hexanes solvent system).Light yellow colored oil (0.292 g, 
83%). TLC Rf  = 0.74 (30% ethyl acetate /70% hexanes); IR (neat) 3061, 2925, 1503, 1454, 1384 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.61-7.52 (m, 5H), 5.43-5.38 (m, 1H), 5.06-5.01 (m, 1H), 
4.07 (d, J = 8.0 Hz, 2H), 2.15-2.01 (m, 2H), 1.69 (s, 3H), 1.58 (s, 3H), 1.26 (s, 3H); 
13
C NMR 
(100 MHz, CDCl3) δ 154.3, 143.1, 133.7, 131.8, 130.0, 123.6, 117.4, 116.7, 39.5, 31.9, 26.4, 
25.6, 23.4, 17.7, 16.3. 
 
 (Z)-5-[(3,7-Dimethyl-2,6-octadienyl)thio]-1-phenyl-1H-tetrazole (178).
88
 Prepared by 
General Procedure 2 from the known imidate.
104
 Purified by Method A (30% ethyl acetate /70% 
hexanes solvent system). Clear colored oil (0.292 g, 88%). TLC Rf  = 0.57 (30% ethyl acetate 
/70% hexanes); IR (neat) 3052, 2967, 2857, 1500, 1448, 1383 cm
-1
; 
1
H NMR (400 MHz, CDCl3) 
δ 7.66-7.50 (m, 5H), 5.45-5.41 (m, 1H), 5.13-5.08 (m, 1H), 4.06 (d, J = 8.0 Hz, 2H), 2.18-2.07 
(m, 4H), 1.75 (s, 3H), 1.66 (s, 3H), 1.58 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 154.3, 143.2, 
133.6, 132.1, 129.9, 129.6, 123.6, 123.4, 117.3, 31.9, 31.3, 26.3, 25.5, 23.3, 17.6. 
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1-Phenyl-5-(2-propyn-1-ylthio)-1H-tetrazole (180).
88
 Prepared by General Procedures 2 and 3 
from the commercially available alcohol or known imidate. 
105
 Purified by Method A (20% ethyl 
acetate /80% hexanes solvent system). Brown colored solid (0.250 g, 96%). mp = 78-79°C, lit = 
97-98°C; TLC Rf  = 0.421 (20% ethyl acetate /80% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 
7.61-7.55 (m, 5H), 4.17 (d, J = 2.8 Hz, 2H), 2.18 (m, 1H); 
13
C NMR (100 MHz, CDCl3) δ 153.1, 
133.6, 130.6, 130.1, 123.9, 73.3, 22.0. 
 
2-(((1-Phenyl-1H-tetrazol-5-yl)thio)methyl)isoindoline-1,3-dione (181). Prepared by General 
Procedure 2 from the known imidate.
98 
 Purified by Method A (40% acetone /60% hexanes 
solvent system followed by trituration with methanol and filtered). White colored solid (0.256 g, 
78%). mp = 84.3-85.6°C; TLC Rf  = 0.45 (40% acetone /60% hexanes); IR (neat) 3064, 3015, 
1777, 1722 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.88-7.86 (m, 2H), 7.77-7.75 (m, 2H), 7.57-7.49 
(m, 5H), 5.47 (s, 2H) ;
 13
C NMR (75 MHz, CDCl3) δ 166.3, ,134.6, 131.7, 130.3, 127.7, 124.2, 
123.9, 39.9, 30.9. Anal. calcd for C16H11N5O2S: C, 56.96; H, 3.29; N, 20.76. Found: C, 56.87; H, 
3.26; N, 20.81. 
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5-(Methylthio)-1-phenyl-1H-tetrazole (183).
106
 Prepared by General Procedure 2 from the 
commercially available methyl 2,2,2-trichloroacetimidate.
 
 Purified by Method A (25% ethyl 
acetate /75% hexanes solvent system). White colored solid (0.081 g, 75%). mp = 77.2-77.8°C, lit 
= 81-82°C;
 
TLC Rf  = 0.31 (25% ethyl acetate /75% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 
7.51-7.47 (m, 5H), 2.75 (s, 1H); 
13
C NMR (100 MHz, CDCl3) δ 155.1, 133.8, 130.3, 129.9, 
123.8, 15.5. 
 
5-(Ethylthio)-1-phenyl-1H-tetrazole (185).
108 
 Prepared by General Procedure 2 from the 
commercially available ethyl 2,2,2-trichloroacetimidate.
 
 Purified by Method A (20% ethyl 
acetate /80% hexanes solvent system). Yellow colored oil (0.225 g, 81%). TLC Rf  = 0.33 (20% 
acetone /80% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.58-7.51 (m, 5H), 3.42 (q, J = 7.2 Hz, 
2H), 1.50 (t, J = 7.2 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 154.3, 133.7, 130.0, 129.8, 123.8, 
22.5, 14.5. 
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5-(Isopropylthio)-1-phenyl-1H-tetrazole (187).
107 
 Prepared by General Procedure 2 from the 
known imidate.
106
 Purified by Method B (35% DCM /65% hexanes). Yellow colored oil (0.689 
g, 38%). TLC Rf  = 0.64, 0.62 (35% DCM /65% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.58-
7.52 (m, 5H), 4.16-4.09 (m, 1H), 1.51 (d, J = 6.8 Hz, 6H); 
13
C NMR (100 MHz, CDCl3) δ 154.1, 
133.7, 130.1, 129.7, 124.0, 39.8, 23.3. 
 
1-(tert-butyl)-4-phenyl-1H-tetrazole-5(4H)-thione (189).
64
 Prepared by General Procedure 2 
from the commercially available tert-butyl 2,2,2-trichloroacetimidate.
 
  Purified by Method A 
(10% ethyl acetate /90% hexanes solvent system). Cream colored solid (0.043 g, 16%). mp = 92-
94°C; TLC Rf  = 0.80 (10% ethyl acetate /90% hexanes); IR (neat) 3070, 2960, 2925 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 7.61-7.55 (m, 5H), 1.65 (s, 9H); 
13
C NMR (75 MHz, CDCl3) δ 152.9, 
133.4, 130.0, 129.6, 124.7, 50.6, 30.7. Anal calcd for C11H14N4S: C, 56.38; H, 6.02; N, 23.91. 
Found: C, 56.45; H, 5.91; N, 24.18. 
 
5-(Butylthio)-1-phenyl-1H-tetrazole (197).
26  
Prepared by General Procedure 3 from the 
commercially available alcohol. Purified by Method A (10% acetone /90% hexanes solvent 
system). Light Yellow oil (0.199 g, 63%). TLC Rf  = 0.22 (10% acetone /90% hexanes); 
1
H 
NMR (400 MHz, CDCl3) δ 7.60-7.53 (m, 5H), 3.33 (t, J = 7.6 Hz, 1H), 1.75-1.85 (m, 2H), 1.41-
83 
 
1.54 (m, 2H), 0.88 (t, J = 7.6 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 154.5, 133.7, 130.0, 
129.7, 123.9, 33.0, 31.0, 21.7, 13.4. 
 
5–[(α-Cholestan-3α)thio]-1-phenyl-1H-tetrazole (199). Prepared by General Procedures 2 and 
3 from the known imidate
109
 or alcohol (in toluene).
 
 Purified by Method A (10% ethyl acetate 
/90% hexanes solvent system). Yellow solid (0.303 g, 48%). mp = 127.7-128.4°C; TLC Rf  = 
0.51 (10% ethyl acetate /90% hexanes); IR (neat) 2929, 2865, 1642, 1597 cm
-1
; 
1
H NMR (400 
MHz, CDCl3) δ 7.61-7.52 (m, 5H), 4.57 (br s, 1H), 2.12-0.78 (m, 42H), 0.64 (s, 3H); 
13
C NMR 
(75 MHz, CDCl3) δ 154.7, 133.8, 129.9, 129.7, 124.1, 56.5, 56.3, 54.1, 47.9, 42.6, 41.8, 39.9, 
39.5, 36.4, 36.2, 35.8, 35.4, 33.8, 31.8, 28.3, 28.2, 28.0, 27.3, 24.1, 23.9, 22.8, 22.6, 20.8, 18.7, 
12.1, 11.9; Anal. calcd for C34H52N4S: C, 74.40; H, 9.55; N, 10.21. Found: C, 74.41; H, 9.52; N, 
10.11. 
 
5α-Cholestan-3α-2,2,2-trichloroacetimidate (204).
109
  Prepared by General Procedure 1 from 
commercially available alcohol. Purified by Method A (10% ethyl acetate/ 80% hexanes/ 5% 
triethylamine solvent system). White colored solid (0.849 g, 91%). TLC Rf  = 0.58 (10% ethyl 
acetate /80% hexanes/ 5% triethylamine); 
1
H NMR (400 MHz, CDCl3) δ 8.18 (br s, 1H), 5.13 (s, 
1H) 1.98 – 0.73 (m, 42H), 0.66 (s, 3H).  
84 
 
 
5–[(α-Cholestan-3β)thio]-1-phenyl-1H-tetrazole (205).
109
 Prepared by General Procedure 2 
from the starting imidate 204 (in toluene).
 
 Purified by Method A (5% ethyl acetate /95% 
hexanes solvent system.) Light yellow colored solid (0.226 g, 42%). TLC Rf  = 0.46 (10% ethyl 
acetate /90% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.58 – 7.51 (m, 5H), 3.95 – 3.84 (m, 1H), 
2.14 – 2.09 (m, 1H), 1.99 – 0.73 (42H), 0.72 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 153.9, 
133.8, 129.9, 129.7, 123.9, 56.4, 56.3, 54.2, 47.3, 46.9, 42.6, 39.9, 39.5, 38.7, 36.1, 35.8, 35.5, 
35.4, 31.9, 29.0, 28.5, 28.2, 28.0, 24.2, 23.9, 22.8, 22.6, 21.0, 18.7, 12.2, 12.1. 
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Chapter 3. Etherification Utilizing Trichloroacetimidates  
Under Thermal Conditions 
 
 
3.1 Introduction 
 
As mentioned in Chapter 1, the literature contains numerous methods to introduce ether 
and ester protecting groups by alkylation; however it comes with the caveat of the requirement of 
an external promoter or harsh conditions.
1-100 
Trichloroacetimidates are a facile method to 
introduce ether and ester
 
protecting groups and are easily formed from alcohols (Scheme 3). 
Many trichloroacetimidates are also commercially available. Previous literature typically 
requires that the imidate be activated by an external promoter for etherification; these promoters 
usually are Brønsted acids, Lewis acids or transition metal catalysts.
1-9,24-27,70,75,76,78 
Recently 
within the Chisholm group it was found that S – alkylation
101
 and esterifications
102,103
 utilizing 
trichloroacetimidates could occur without the addition of an added catalyst. Therefore it was 
theorized that ether formation might be possible under similar reaction conditions. This would 
provide a mild alternative for the conversion of alcohols to ethers without an external promoter 
and expand the applicability of trichloroacetimidate alkylations to substrates containing acid-
sensitive functionality. To our knowledge, no precedent has shown that ether formation with 
trichloroacetimidates may be performed solely under thermal conditions without an added 
catalyst,
73
 and this improvement on the known methodology could be quite useful in complex 
substrates. As proposed in Scheme 25, we suspect that the substitution reaction may occur in a 
similar manner as the thioetherification, which is through either an SN1 or SN2 pathway (stepwise 
proton transfer). Obviously, the proton transfer step will be more difficult, as alcohols are less 
acidic than thiols or carboxylic acids. Still, under more vigorous reaction conditions the 
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etherification may be possible. This chapter focuses on defining the limits of this new 
etherification procedure, particularly on the reactivity of both diphenylmethyl and 4-methoxy 
benzyl trichloroacetimidates in these reactions. 
 
 
Scheme 25: Possible Mechanistic Pathway of Ether Generation 
 
 
3.2  Reaction Development 
O - Diphenylmethyl (DPM) trichloroacetimidate 19 was utilized as the initial electrophile 
in the etherification. As diphenylmethyl is a common protecting group used in organic synthesis 
(often as a surrogate for benzyl) the installation of this group would be useful in organic 
synthesis.
3
 Additionally, the DPM imidate 19 is a conveniently handled white solid that can be 
stored for long periods of time at 0°C,
5,102 
so it may be a practical "on-demand" etherification 
reagent. When 1-octadecanol 210 and 1.2 equivalents of 19 were combined in toluene and heated 
to 50 °C for 24 hours, only 24% of the desired ether 211 could be isolated (Table 14, Entry 1). A 
significant amount of starting material was also recovered. While the yield was low this result 
provided evidence for the initial hypothesis that this etherification could occur solely under 
thermal conditions. We then increased the temperature to refluxing in toluene (111 °C), which 
provided the desired ether in a much more desirable 85% yield. Several other solvents were also 
104 
 
investigated, including THF, which proved to be ideal for thioetherifications; however the yield 
did not improve significantly. Therefore, toluene at reflux for 24 hours (Entry 2) was chosen as 
the standard reaction conditions to generate the desired etherification products. 
Table 14: Reaction of DPM trichloroacetimidate with 1-octadecanol 
 
 
 
Entry Solvent Temperature Yield
b
 
1 toluene 50 °C 24% 
2 toluene 111 °C 85% 
3 α, α, α - trifluorotoluene 102 °C 62% 
4 THF 66 °C 36% 
5 dichloromethane 40 °C 18% 
6 1,2-dichloroethane 83 °C 66% 
7 1,4-dioxane 101 °C 60% 
8 acetonitrile 82 °C 28% 
9 DMF 110 °C 33% 
a
All reactions were performed at 0.25M for 24 h in the noted solvent. 
b
Isolated yields. 
 
With reaction conditions in hand, we then investigated the scope of this etherification 
methodology with regard to the alcohol reaction partner. Benzylic alcohols were excellent 
substrates, generating DPM ethers under essentially neutral conditions very efficiently regardless 
if an electron - withdrawing or – donating group is present. More specifically, the 4-nitrobenzyl 
alcohol afforded ether 218 in 88% yield while the 4-methoxybenzyl alcohol provided ether 216 
in 71% yield. 
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Table 15: Reaction of DPM Imidate with Benzylic Alcohols 
 
 
This methodology was also extended towards simple primary and secondary alcohols to 
obtain the desired ethers in respectable yields. Propargyl alcohol proved to be an exceptional 
substrate, providing the corresponding DPM ether in nearly quantitative yields. Additionally 
cinnamyl alcohol 218, which has consistently been a challenging substrate for some other 
etherification reagents,
8
 gave an 88% yield of the desired ether. 
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Table 16: Reaction of DPM Imidate with Alkyl and Allylic Alcohols 
 
 
 
Table 17 further demonstrates the general nature of this methodology with DPM imidate 
with acid/base labile compounds, and even chiral alcohols could tolerate this transformation 
without degradation, racemization, isomerization, or elimination. Most notably, epoxide 227 as 
well as β – trimethylsiylethanol, 229, which can undergo Peterson elimination
104
 successfully 
yielded the desired products in 65% and 79% yield, respectively. We have established that 
carbohydrate alcohols were just as capable of generating the desired DPM ether, with the 
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formation of ether 222 in 73% yield. This demonstrates the versatility of trichloroacetimidates as 
well as verifies the initial hypothesis that O-alkylation may occur in multiple substrates without 
an added catalyst with the DPM trichloroacetimidate. 
Table 17: Reaction of DPM Imidate with Acid-Sensitive Alcohols 
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We then continued to investigate more complex alcohols in the form of phenolic and 
phenolic-like substrates (Table 18). More specifically, the electron-poor thiophene provided 
ether 233 in 53% yield, the base sensitive N – hydroxyphthalimide afforded the etherification 
product in 232 80% yield, and the 4-nitro and 4-methoxy phenols in 61% and 91% yield, 
respectively.  
 
Table 18: Reaction of DPM Imidate with Phenols and Phenol-Like Alcohols 
 
 
 
 
With the completion of our expansive investigation into ether formation with DPM 
imidate,
5
 we then changed the imidate electrophile to a more commonly used protecting group, 
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4-methoxybenzyl (PMB).
9,11,18,24,83
  Given the previous ideal conditions for our etherification 
methodology with DPM was toluene at refluxing conditions, we presumed this could be an high-
yielding set of conditions for etherification utilizing PMB imidate; however, this was not the 
case. Although toluene yielded the desired etherification product in 70% yield (Table 19, Entry 
1), which is respectable and proves that this alkylation can be completed without an exogenous 
catalyst, we observed a considerable amount of starting materials and also some Friedel-Crafts 
products between the PMB imidate and the toluene. The elevated temperatures were decreased in 
an attempt to minimize the formation of Friedel-Crafts products, however the yield of the desired 
ether significantly decreased. Switching the solvent to the less activated α,α,α-trifluorotoluene 
was also explored, as the electron-withdrawing trifluoromethyl group should inhibit the 
formation of Friedel-Crafts alkylation products. This resulted in a slightly higher yielding 
etherification product, 73%; however there were still some starting materials present. Other 
modifications to the reaction conditions such as varying temperatures, varying reaction 
concentration, and the addition of drying agents like MgO were also investigated, however no 
further improvement to the yield was found.  
Table 19: Reaction of PMB trichloroacetimidate with 1-octadecanol 
 
 
Entry Solvent Temperature Yield
b
 
1 toluene 111 °C 70% 
2 toluene 50 °C 23% 
3 α, α, α - trifluorotoluene 102 °C 73% 
4 THF 66 °C 40% 
5 dichloromethane 40 °C 17% 
6 1,4-dioxane 101 °C 25% 
7 acetonitrile 82 °C 18% 
8 DMF 110 °C 11% 
a
All reactions were performed at 1.0M for 18 h in the noted solvent. 
b
Isolated yields. 
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The generality of this methodology with the PMB imidate was then investigated. The 
benzylic alcohols in Table 20 were varied from phenyl, methyl and hydrogen at the alpha 
position with PMB imidate 16, and the yields did not vary greatly based on substitution between 
methyl and phenyl, 68%, and 67% respectively, but when a primary benzyl alcohol was used a 
significantly higher yield was obtained (81% to form ether 244). The less reactive PMB imidate 
seemed to be more significantly affected by the steric environment near the reactive alcohol. 
Additionally functionalized benzylic substrates afforded the desired ether in good yield; more 
specifically, the 4-methoxybenzyl and 4-nitrobenzyl alcohols afforded ethers 245 and 246 in 
78% and 85% yield. 
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Table 20: Reaction of PMB Imidate with Benzylic Alcohols 
 
 
Phenols and an hydroxy imide alcohol were just as capable of generating the desired 
ether as benzylic alcohols, as shown in Table 21. Electron poor phenols proved to be good 
substrates, but the electron rich 4-methoxyphenol gave a deceased yield. This may indicate that 
the acidity of the alcohol plays a more significant role in the rate of the etherification reaction 
with the less reactive PMB imidate. 
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Table 21: Reaction of PMB Imidate with Phenols and Hydroxy Imide 
 
 
 
 
 
Although preliminary, similar to our DPM investigation we found our methodology could 
be expanded to simple and complex allylic and propargylic substrates (Table 22). We have 
shown the difficult cinnamyl alcohol substrate could be isolated in 52% yield while propargyl 
alcohol again proved to be an excellent substrate yielding 82% of the desired ether, 253.  
 
 
 
113 
 
Table 22: Reaction of PMB Imidate with Allylic Alcohols 
 
 
 
 
  
Some more complex substrates were then investigated (Table 23). Specifically, 254 and 
255 have shown that we can isolate the β – trimethylsiylethanol and cyclohexanol etherification 
products in the absence of an exogenous catalyst, 68% and 47%, respectively.  
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Table 23: Reaction of PMB Imidate with Alkyl Alcohols 
 
 
 
 
 
 
 
3.3 Summary 
 
 
 In summary, we have developed a method for the protection of alcohols as their 
corresponding DPM
5
 and PMB ethers solely under thermal conditions without the need of an 
acid, base, or transition metal catalyst by utilizing a trichloroacetimidate. Using various alcohols 
as substrates, we have shown that the reaction tolerates considerable variation of alcohol 
nucleophiles. A wide-range of acid and/or base sensitive substrates was investigated yielding the 
respective etherification products in moderate to high yields. These mild reaction conditions for 
the installation of common protecting groups have shown compatibility with numerous 
polyfunctional molecules as no racemization or elimination products were observed. Typically 
only the inert trichloroacetamide and trace amounts of respective ether dimer (DPM-O-DPM and 
115 
 
PMB-O-PMB) were isolated as side products. These mild conditions for the thermal protection 
of alcohols as DPM or PMB ethers provides a general method and could expand their relevance 
to sensitive substrates in synthetic applications. The yields of the DPM ethers are significantly 
greater than the PMB ethers in many cases. Currently, on-going investigations within the 
Chisholm group are underway to improve the overall yields of the PMB etherification 
methodology. 
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3.4 Experimental 
 
 
General Methods: All anhydrous reactions were run under a positive pressure of argon or 
nitrogen. All syringes, needles, and reaction flasks required for anhydrous reactions were dried in 
an oven and cooled under an N2 atmosphere or in a desiccator. Dichloromethane and THF were 
dried by passage through an alumina column following the method of Grubbs (Pangborn, A. B.; 
Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518). 
Triethylamine was distilled from CaH2. All other reagents and solvents were purchased from 
commercial sources and used without further purification.  
Analysis and Purification. Analytical thin layer chromatography (TLC) was performed on 
precoated glass backed plates (silica gel 60 F254; 0.25 mm thickness). The TLC plates were 
visualized by UV illumination and by staining. Solvents for chromatography are listed as 
volume:volume ratios. Flash column chromatography was carried out on silica gel (40-63 μm). 
Melting points were recorded using an electrothermal melting point apparatus and are 
uncorrected. Elemental analyses were performed on an elemental combustion system ECS 4010 
analyzer with a thermal conductivity detector and 2 meter GC column maintained at 50 °C. 
Identity. Proton (
1
H NMR) and carbon (
13
C NMR) nuclear magnetic resonance spectra were 
recorded at 300 or 400 MHz and 75 or 100 MHz respectively. The chemical shifts are given in 
parts per million (ppm) on the delta (δ) scale. Coupling constants are reported in hertz (Hz). The 
spectra were recorded in solutions of deuterated chloroform (CDCl3), with residual chloroform (δ 
7.26 ppm for 
1
H NMR, δ 77.23 ppm for 
13
C NMR) or tetramethylsilane (δ 0.00 for 
1
H NMR, δ 
0.00 ppm for 
13
C NMR) as the internal reference. Data are reported as follows: (s = singlet; d = 
doublet; t = triplet; q = quartet; p = pentet; dd = doublet of doublets; dt = doublet of triplets; td = 
triplet of doublets; tt = triplet of triplets; qd = quartet of doublets; ddd = doublet of doublet of 
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doublets; br s = broad singlet). Where applicable, the number of protons attached to the 
corresponding carbon atom was determined by DEPT 135 NMR. Infrared (IR) spectra were 
obtained as thin films on NaCl plates by dissolving the compound in CH2Cl2 followed by 
evaporation or as KBr pellets. 
 
1) General Procedure for Preparing Trichloroacetimidates: 
Benzhydrol (10.125 g, 54.9 mmol) was added to a 250 mL flame dried round-bottom flask. 55 
mL of dry DCM was added to dissolve the alcohol while under an argon atmosphere. 1,8-
diazabicyclo[5.4.0]undec-7-ene (0.83 mL, 5.5 mmol) and trichloroacetonitrile (6.1 mL, 82.4 
mmol) were then added to the reaction. This reaction mixture was allowed to stir for 20 hours at 
room temperature. The reaction mixture was concentrated under reduced pressure then pre-
adsorbed on silica gel, and purified by silica gel column chromatography using 20% ethyl 
acetate/ 75% hexanes/ 5% triethylamine. This provided desired trichloroacetimidate as a white 
solid (9.99 g, 56%). 
 
2) General Procedure for Generating DPM Etherification Product: 
4-nitrobenzyl alcohol (0.251 g, 1.64 mmol) was placed into a 25 mL flame dried round-bottom 
flask and was dissolved in 4 mL of dry toluene. Diphenylmethyl 2, 2, 2 - trichloroacetimidate 
(0.648 g, 1.97 mmol) was added to the stirring reaction flask. The reaction mixture was heated to 
reflux while under an argon atmosphere for 18 hours. The reaction mixture was allowed to cool 
to room temperature, and was concentrated under reduced pressure. This was then pre-adsorbed 
on silica gel and purified by column chromatography using 40% dichloromethane /60% hexanes. 
This provided desired ether as a cream-colored solid (0.462 g, 88%). 
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3) General Procedure for Generating PMB Etherification Product: 
Benzhydrol (0.737 g, 4 mmol) was placed into a 25 mL flame dried round-bottom flask and was 
dissolved in 4 mL of anhydrous α,α,α - trifluorotoluene. 4 – methoxy benzyl 2,2,2 - 
trichloroacetimidate (2.268 g, 8 mmol) was added to the stirring reaction flask. The reaction 
mixture was heated to reflux while under an argon atmosphere for 18 hours. The reaction 
mixture was allowed to cool to room temperature, and was concentrated under reduced pressure. 
This was then pre-adsorbed on silica gel and purified by column chromatography using 20% 
ethyl acetate /80% hexanes. This provided desired ether as a clear- colored oil (0.791 g, 68%). 
 
General Procedures for the Purification of Ethers: 
The reaction mixture was pre-adsorbed on silica gel and purified by silica gel  
chromatography using the listed solvent system. In some cases the trichloroacetamide was 
difficult to remove chromatographically. When this occurred, the reaction mixture was cooled to 
room temperature, concentrated under reduced pressure and dissolved in 50 mL of ethyl acetate. 
The organic layer was washed three times with 25 mL of 2M NaOH and then once with 25 mL 
of saturated NaCl. The organic layer was dried over anhydrous sodium sulfate and concentrated 
under reduced pressure.  
. 
 
Octadecyloxydiphenylmethane (211).  Prepared by General Procedure 2 from the known 
imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. White colored solid (0.273 
g, 85%). mp = 47-48 °C;  TLC Rf = 0.80 (10% ethyl acetate/hexanes); IR (solid film from 
CH2Cl2) 3027, 2923, 2852, 1493, 1453, 1097 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.21-7.37 (m, 
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10H), 5.33 (s, 1H), 3.44 (t, J = 6.6 Hz, 2H), 1.60-1.67 (m, 2H), 1.26 (m, 30H), 0.88 (t, J = 6.3 
Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ 142.9, 128.5, 127.5, 127.2, 83.8, 69.4, 32.2, 30.1, 29.94, 
29.91, 29.87, 29.85, 29.7, 29.6, 26.5, 22.9, 14.3 (several signals in the aliphatic region were not 
resolved). Anal calcd for C31H48O: C, 85.26; H, 11.08. Found: C, 85.18; H, 11.13. 
 
Benzyloxydiphenylmethane (213).
85
 Prepared by General Procedure 2 from the known 
imidate.
6 
Purified by 25% ethyl acetate /75% hexanes solvent system. Clear colored oil (0.238 g, 
94%). TLC Rf = 0.92 (25% ethyl acetate/hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.24-7.42 (m, 
15H), 5.46 (s, 1H), 4.56 (s, 2H); 
13
C NMR (75 MHz, CDCl3) δ 142.4, 138.6, 128.6, 128.6, 127.9, 
127.72, 127.65, 127.3, 82.7, 70.7.  
 
 ((1-Phenylethoxy)methylene)dibenzene (214).
86
 Prepared by General Procedure 2 from the 
known imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. Clear colored oil 
(0.434 g, 92%). TLC Rf = 0.85 (10% acetone/hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.20-7.41 
(m, 15H), 5.31 (s, 1H), 4.51 (q, J = 6.6 Hz, 1H), 1.53 (d, J = 6.3 Hz, 3H); 
13
C NMR (75 MHz, 
CDCl3) δ 143.9, 143.0, 142.2, 128.7, 128.4, 128.3, 127.73, 127.70, 127.67, 127.3, 127.1, 126.7, 
80.2, 75.1, 24.5. 
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 (4-Methoxybenzyloxy)diphenylmethane (216).
87
 Prepared by General Procedure 2 from the 
known imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. Clear colored oil 
(0.314 g, 71%). TLC Rf = 0.50 (10% ethyl acetate/hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.24-
7.41 (m, 12H), 6.91 (d, J = 8.7 Hz, 2H), 5.45 (s, 1H), 4.50 (s, 2H), 3.83 (s, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 159.3, 142.4, 130.6, 129.5, 128.5, 127.6, 127.3, 113.9, 82.2, 70.3, 55.4.  
 
 (((4-Nitrobenzyl)oxy)methylene)dibenzene (218). Prepared by General Procedure 2 from the 
known imidate.
6 
Purified by 40% DCM/60% hexanes solvent system. Off-white colored solid 
(0.460 g, 88%). mp = 62-64 °C; TLC Rf = 0.59 (40% DCM/60% hexanes); IR (solid film from 
CH2Cl2) 3062, 3028, 2922, 2857, 1493, 1347, 1288 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 8.19 (d, 
J = 8.7 Hz, 2H), 7.52 (d, J = 8.1 Hz, 2H), 7.25-7.40 (m, 10H), 5.46 (s, 1H), 4.62 (s, 2H); 
13
C 
NMR (75 MHz, CDCl3) δ 147.4, 146.1, 141.6, 128.6, 127.8, 127.7, 127.0, 123.6, 83.5, 69.5. 
Anal calcd for C20H17NO3: C, 77.22; H, 5.37; N, 3.49. Found: C, 77.20; H, 5.31; N, 3.44. 
 
 ((tert-Pentyloxy)methylene)dibenzene (220).
88
 Prepared by General Procedure 2 from the 
known imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. Clear colored oil 
(0.489 g, 85%). TLC Rf = 0.92 (10% ethyl acetate/hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.41 
(d, J = 6.9 Hz, 4H), 7.33 (t, J = 7.2 Hz, 4H), 7.20-7.26 (m, 2H), 5.60 (s, 1H), 1.62 (q, J = 7.5 Hz, 
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2H), 1.17 (s, 6H), 0.91 (t, J = 7.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 145.6, 128.3, 127.0, 
126.9, 76.9, 75.6, 34.8, 26.1, 8.9. 
 
 ((Cyclohexyloxy)methylene)dibenzene (213).
89
 Prepared by General Procedure 2 from the 
known imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. Clear colored oil 
(0.494 g, 93%). TLC Rf = 0.68 (10% ethyl acetate/hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.24-
7.40 (m, 10H), 5.58 (s, 1H), 3.35-3.44 (m, 1H), 1.93 (dd, J = 9.0, 6.0 Hz, 2H), 1.76-1.82 (m, 
2H), 1.41-1.58 (m, 3H), 1.26 (q, J = 8.3 Hz, 3H); 
13
C NMR (75MHz, CDCl3) δ143.3, 128.4, 
127.31, 127.26, 80.1, 75.1, 32.5, 26.0, 24.2. 
 
1-(Benzhydryloxy)adamantine (215). Prepared by General Procedure 2 from the known 
imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. Orange colored solid 
(0.383 g, 92%). mp = 64-66 °C; TLC Rf = 0.71 (10% ethyl acetate/hexanes); IR (solid film from 
CH2Cl2) 3025, 2905, 2850, 1492, 1451, 1354, 1082 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.20-
7.39 (m, 10H), 5.80 (s, 1H), 2.14 (s, 3H), 1.83 (bs, 6H), 1.62 (bs, 6H); 
13
C NMR (100 MHz, 
CDCl3) δ 145.3, 128.2, 127.2, 126.9, 74.4, 73.8, 43.0, 36.6, 30.8. Anal calcd for C23H26O: C, 
86.75; H, 8.23. Found: C, 86.72; H, 8.18. 
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Diphenyl(prop-2-ynyloxy)methane (216).
90
 Prepared by General Procedure 2 from the known 
imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. Yellow colored oil (0.384 
g, 97%). TLC Rf = 0.86 (10% ethyl acetate/hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.24-7.40 
(m, 10H), 5.68 (s, 1H), 4.17 (d, J = 2.4 Hz, 2H), 2.46 (t, J = 2.4 Hz, 1H);
 13
C NMR (100 MHz, 
CDCl3) δ 141.3, 128.6, 127.9, 127.5, 81.8, 79.9, 74.8, 56.0. 
 
Cinnamyloxydiphenylmethane (218).
91
 Prepared by General Procedure 2 from the known 
imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. White colored solid (0.395 
g, 88%). mp = 55-57 °C; TLC Rf = 0.58 (25% ethyl acetate/hexanes); 
1
H NMR (300 MHz, 
CDCl3) δ 7.23-7.42 (m, 15H), 6.63 (d, J = 15.9 Hz, 1H), 6.32-6.41 (m, 1H), 5.51 (s, 1H), 4.20 
(dd, J = 6.0, 1.5 Hz, 2H); 
13
C NMR (75 MHz, CDCl3) δ 142.3, 136.9, 132.3, 128.6, 128.5, 127.7, 
127.5, 127.1, 126.6, 126.3, 82.8, 69.4. 
 
 (R)-Ethyl 2-(benzhydryloxy)propanoate (220).
92
 Prepared by General Procedure 2 from the 
known imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. Clear colored oil 
(0.434 g, 90%).  α  
     -103.8 (c 1.04, DCM); TLC Rf = 0.57 (10% ethyl acetate/hexanes); 
1
H 
NMR (300 MHz, CDCl3) δ 7.26-7.41 (m, 10H), 5.57 (s, 1H), 4.16-4.28 (m, 2H), 4.08 (q, J = 6.0 
Hz, 1H), 1.49 (d, J = 9.0 Hz, 3H), 1.30 (t, J = 9.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 173.6, 
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142.1, 141.1, 128.7, 128.4, 128.0, 127.7, 127.6, 127.5, 82.8, 72.7, 61.0, 19.0, 14.4. Chiral HPLC 
analysis: Chiralcel OD (heptane/2-PrOH = 99/1, 1.0 mL/min, 254 nm, 25 °C): t(R enantiomer) = 5.3 
min, t(S enantiomer) = 5.8 min. 
 
Methyl 2,3,4-Tri-O-benzyl-6-O-diphenylmethyl-α-D-glucopyranoside (222).
7
 Prepared by 
General Procedure 2 from the known imidate.
6 
Purified by 15% ethyl acetate /85% hexanes 
solvent system. Clear colored oil (0.750 g, 73%). TLC Rf = 0.43 (15% ethyl acetate/85% 
hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.55-7.18 (m, 25 H), 5.50 (s, 1H), 5.13 (d, J = 10.8 Hz, 
1H), 4.98 (t, J = 11.1 Hz, 2H), 4.93 (d, J = 12.0 Hz, 1H), 4.82 (d, J = 11.7 Hz, 1H), 4.80 (d, J = 
3.6 Hz, 1H), 4.68 (d, J = 11.1 Hz, 1H), 4.16 (t, J = 9.3 Hz, 1H), 3.89-3.99 (m, 1H), 3.77-3.84 
(m, 3H), 3.72 (dd, J = 3.6, 9.6 Hz, 1H), 3.49 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ 142.2, 142.1, 
138.8, 138.3, 138.2, 128.5, 128.4, 128.36, 128.1, 127.9, 127.8, 127.7, 127.5, 127.4, 127.2, 126.9, 
98.1, 84.1, 82.3, 80.1, 78.0, 75.9, 75.1, 73.4, 70.3, 67.9, 55.1. 
 
 (S)-Benzyl 3-(benzhydryloxy)-2-(((benzyloxy)carbonyl)amino)propanoate (224). Prepared 
by General Procedure 2 from the known imidate.
6 
Purified by 10% ethyl acetate /90% hexanes 
solvent system. Clear colored oil (0.273 g, 91%).  α  
     -12.5 (c 1.26, CHCl3); TLC Rf = 0.18 
(10% ethyl acetate/hexanes); IR (solid film from CH2Cl2) 3434, 3341, 3062, 3030, 2949, 2876, 
1722, 1498, 1339, 1197, 1067 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.07-7.30 (m, 20H), 5.63 (d, 
J = 12.0 Hz, 1H), 5.19 (s, 1H), 5.12 (d, J = 4.0 Hz, 2H), 5.04 (s, 2H), 4.49 (dt, J = 2.8 Hz, 1H), 
124 
 
3.84 (dd, J = 9.4, 2.8 Hz, 1H), 3.60 (dd, J = 9.4, 3.1 Hz, 1H);
 13
C NMR (75 MHz, CDCl3) 
δ170.3, 156.1, 141.6, 141.4, 136.4, 135.4, 128.7, 128.65, 128.6, 128.5, 128.4, 128.3, 128.2, 
127.7, 127.0, 126.9, 84.2, 69.0, 67.4, 67.2, 54.8 . (note: two signals in the aromatic region were 
not resolved.) Anal calcd for C31H29NO5: C, 75.13; H, 5.90; N, 2.83. Found: C, 74.94; H, 5.97; 
N, 3.00. Chiral HPLC analysis: Chiralcel OD (heptane/2-PrOH = 90/10, 1.0 mL/min, 254 nm, 25 
°C): t(S enantiomer) = 16.7 min, t(R enantiomer) = 23.9 min. 
 
Ethyl 3-(benzhydryloxy)-3-phenylpropanoate (226). Prepared by General Procedure 2 from 
the known imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. White colored 
solid (0.178 g, 96%). mp = 73-74 °C; TLC Rf = 0.53 (10% ethyl acetate/hexanes); IR (solid film 
from CH2Cl2) 3061, 3028, 2980, 1736, 1493, 1453, 1268, 1172, 1052 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3) δ 7.19-7.40 (m, 15H), 5.24 (s, 1H), 4.81 (ddd, J = 1.3, 4.9, 9.0 Hz, 1H), 4.00-4.23 (m, 
2H), 2.96 (ddd, J = 1.4, 9.0, 14.7 Hz, 1H), 2.65 (ddd, J = 1.2, 4.9, 14.7 Hz, 1H), 1.21 (td, J = 1.1, 
7.1 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 170.8, 142.8, 141.3, 140.7, 128.8, 128.6, 128.3, 
128.2, 128.0, 127.9, 127.24, 127.16 126.7, 80.11, 75.7, 60.6, 44.0, 14.3. Anal calcd for 
C24H24O3: C, 79.97; H, 6.71. Found: C, 79.96; H, 6.88. 
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2-((Benzhydryloxy)methyl)-3-phenyloxirane (228).
93
 Prepared by General Procedure 2 from 
the known imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. Clear colored 
oil (0.255 g, 65%) TLC Rf = 0.50 (10% ethyl acetate/hexanes); 
1
H NMR (300 MHz, CDCl3) δ 
7.25-7.44 (m, 15H), 5.53 (s, 1H), 3.86 (dd, J = 11.5, 3.1 Hz, 1H), 3.80 (d, J = 2.0 Hz, 1H) 3.66 
(dd, J = 5.3, 11.5 Hz, 1H), 3.29-3.32 (m, 1H). 
13
C NMR (100 MHz, CDCl3) δ 141.99, 141.94, 
137.1, 128.7, 128.6, 128.4, 127.8, 127.77, 127.5, 127.3, 127.2, 125.9, 84.1, 68.9, 61.4, 56.1. 
 
 (2-(Benzhydryloxy)ethyl)trimethylsilane (230).  Prepared by General Procedure 2 from the 
known imidate.
6 
Purified by 15% DCM/5% triethylamine/ 80% hexanes solvent system. Pale 
yellow colored oil (0.368 g, 79%). TLC Rf = 0.56 (15% DCM/5% triethylamine/ 80% hexanes); 
IR (solid film from CH2Cl2) 3087, 3063, 3029, 2953, 2892, 1452, 1317, 1249 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3) δ 7.36 (dd, J = 6.3, 1.2 Hz, 4H), 7.30 (t, J = 6.6 Hz, 4H), 7.22-7.25 (m, 2H), 
5.35 (s, 1H), 3.56 (t, J = 6.0 Hz, 2H), 1.03 (t, J = 6.0 Hz, 2H), 0.00 (s, 9H); 
13
C NMR (100 MHz, 
CDCl3) δ 144.0, 129.6, 128.5, 128.2, 84.6, 67.6, 19.7, 0.0; Anal calcd for C18H24OSi: C, 76.00; 
H, 8.50; Found: C, 75.77; H, 8.62. 
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2-(Benzhydryloxy)isoindoline-1,3-dione (232).
94
 Prepared by General Procedure 2 from the 
known imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. Yellow colored 
solid (0.323 g, 80%). mp = 160-162 °C; TLC Rf = 0.29 (10% acetone/hexanes); 
1
H NMR (300 
MHz, CDCl3) δ 7.66-7.76 (m, 4H), 7.52-7.56 (m, 4H), 7.29-7.39 (m, 6H), 6.53 (s, 1H); 
13
C NMR 
(100 MHz, CDCl3) δ 163.8, 137.9, 134.4, 128.9, 128.8, 128.5, 128.4, 123.4, 89.7.  
 
Methyl 3-(benzhydryloxy)thiophene-2-carboxylate (234). Prepared by General Procedure 2 
from the known imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. White 
colored solid (0.280 g, 53%). mp = 105-106 °C; TLC Rf = 0.3 (10% ethyl acetate/90% hexanes); 
IR (solid film from CH2Cl2) 3061, 3028, 2948, 1711, 1538, 1228, 1062 cm
-1
; 
1
H NMR (400 
MHz, CDCl3) δ 7.53 (d, J = 7.6 Hz, 4H), 7.35 (t, J = 7.2 Hz, 4H), 7.25–7.28 (m, 3H), 6.74 (d, J = 
5.6 Hz, 1H), 6.27 (s, 1H), 3.90 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ 162.4, 160.1, 141.2, 
130.4, 128.9, 128.1, 126.7, 118.7, 111.6, 85.0, 51.8. Anal calcd for C19H16O3S: C, 70.35; H, 
4.97; Found: C, 70.26; H, 5.02. 
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 ((4-Methoxyphenoxy)methylene)dibenzene (236).
95
 Prepared by General Procedure 2 from the 
known imidate.
6 
Purified by 10% acetone /90% hexanes solvent system. Orange colored solid 
(0.424 g, 91%). mp = 84-85 °C; TLC Rf = 0.42 (10% acetone/hexanes); 
1
H NMR (300 MHz, 
CDCl3) δ 7.26-7.43 (m, 10H), 6.88 (d, J = 9.1 Hz, 2H), 6.75 (d, J = 9.2 Hz, 2H), 6.11 (s, 1H), 
3.73 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ 154.2, 152.4, 141.7, 128.7, 127.8, 127.1, 117.4, 
114.7, 82.8, 55.7. 
 
((4-Nitrophenoxy)methylene)dibenzene (238).
18 
Prepared by General Procedure 2 from the 
known imidate.
6 
Purified by 10% ethyl acetate /90% hexanes solvent system. Pale yellow colored 
solid (0.310 g, 61%). mp = 157-158 °C; TLC Rf = 0.36 (10% ethyl acetate/90% hexanes); 
1
H 
NMR (300 MHz, CDCl3) δ 8.13 (d, J = 9.0 Hz, 2H), 7.28-7.42 (m, 10H), 7.02 (d, J = 9.3 Hz, 
2H), 6.31 (s, 1H); 
13
 C NMR (75 MHz, CDCl3) δ 162.9, 141.6, 139.8, 128.8, 128.3, 126.7, 125.8, 
115.9, 82.5. 
 
1-methoxy-4-((1-phenylethoxy)methyl)benzene (239).
23
  Prepared by General Procedure 3 
from the commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
Purified by 10% 
ethyl acetate /90% hexanes solvent system. Clear colorless oil (0.649 g, 67%). TLC Rf = 0.52 
(10% ethyl acetate/90% hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.35-7.33 (m, 4H), 7.31-7.20 
(m, 3H), 6.85 (d, J = 8.7 Hz, 2H), 4.46 (q, J = 6.6 Hz, 1H), 4.23 (dd, J = 11.4, 46.8 Hz, 2H), 3.75 
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(s, 3H), 1.45 (d, J = 6.3 Hz, 3H);
 13
 C NMR (75 MHz, CDCl3) δ 159.2, 143.9, 130.8, 129.4, 
128.6, 127.5, 126.4, 113.9, 77.0,  70.0, 55.3, 24.3. 
 
1-(benzyloxymethyl)-4-methoxybenzene (244).
67
 Prepared by General Procedure 3 from the 
commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate. Purified by 20% ethyl 
acetate/80% hexanes solvent system. Clear colored oil (0.739 g, 81%). TLC Rf = 0.54 (20% ethyl 
acetate/80% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.34-7.23 (m, 7 H), 6.87 (d, J = 8.4 Hz, 2 
H), 4.51 (s, 2 H), 4.48 (s, 2 H), 3.77 (s, 3 H); 
13
 C NMR (100 MHz, CDCl3) δ 159.1, 138.3, 
130.3, 129.3, 128.3, 127.7, 127.5, 113.7, 71.6, 55.2. 
 
bis(4-methoxybenzyl)ether (245).
20
 Prepared by General Procedure 3 from the commercially 
available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
 Purified by 20% acetone /80% hexanes 
solvent system. Clear colored oil (0.899 g, 78%). TLC Rf = 0.50 (20% acetone/80% hexanes); 
1
H 
NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.8 Hz, 4 H), 6.87 (d, J = 8.8 Hz, 4 H), 4.50 (s, 4 H), 
3.78 (s, 6 H); 
13
 C NMR (100 MHz, CDCl3) δ 159.1, 130.4, 129.3, 113.7, 71.4, 55.2. 
 
1-methoxy-4-(4-nitro-benzyloxymethyl)-benzene (246). Prepared by General Procedure 3 from 
the commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
 Purified by 10% 
acetone/90% hexanes solvent system. Dark yellow colored oil (0.929 g, 85%). TLC Rf = 0.45 
(10% acetone/90% hexanes); IR (neat) 3109, 3076, 3003, 2935, 2838, 1561, 1342, 1302, 1246; 
1
H NMR (400 MHz, CDCl3) δ 8.21 (d, J = 2 Hz, 2 H), 7.51 (d, J = 8.8 Hz, 2 H), 7.26 (d, J = 2 
Hz, 2 H), 6.90 (d, J = 8.8 Hz, 2 H), 4.61 (s, 2 H), 4.55 (s, 2 H), 3.81 (s, 3 H); 
13
 C NMR (100 
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MHz, CDCl3) δ 159.5, 147.3, 146.1, 129.6, 129.5, 129.3, 127.8, 123.6, 114.4, 113.9, 72.5, 70.5, 
55.3, 44.9; Anal. Cald for C15H15NO4: C, 65.92; H, 5.53; N, 5.13. Found: C, 65.80, H, 5.41, N, 
5.00. 
 
1-methoxy-4-((4-methoxybenzyl)oxy)benzene (247).
97
 Prepared by General Procedure 3 from 
the commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
 Purified by 10% ethyl 
acetate/90% hexanes solvent system. Light yellow colored oil (0.381 g, 39%). TLC Rf = 0.56 
(10% ethyl acetate/90% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.08 (d, J = 8.8 Hz, 4H) 6.82 
(d, J = 8.8 Hz, 4H), 3.86 (s, 2H), 3.77 (s, 6 H); 
13
 C NMR (100 MHz, CDCl3) δ 157.9, 135.8, 
129.8, 113.9, 55.3, 40.2. 
 
N-(4-methoxybenzyloxy)phthalimide (250).
97
 Prepared by General Procedure 3 from the 
commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
 Purified by 20% ethyl 
acetate/80% hexanes solvent system. White colored solid (0.657 g, 58%). mp = 134.9-136.3°C; 
TLC Rf = 0.28, 0.57 (20% ethyl acetate/80% hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.82-7.71 
(m, 4 H) 7.45 (d, J = 8.4 Hz, 2 H), 6.88 (d, J = 8.4 Hz, 2 H), 5.15 (s, 2 H), 3.80 (s, 3 H); 
13
 C 
NMR (75 MHz, CDCl3) δ 163.5, 160.4, 134.3, 131.6, 128.8, 125.8, 123.4, 113.9, 79.4, 55.2.  
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 (E)-1-((cinnamyloxy)methyl)-4-methoxybenzene (251). Prepared by General Procedure 3 
from the commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
Purified by 25% 
ethyl acetate/75% hexanes solvent system. Yellow colored oil (0.516 g, 52%). TLC Rf = 0.70 
(25% ethyl acetate/75% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.40 (d, J = 7.2 Hz, 2H), 7.34-
7.30 (m, 4H), 7.25 (d, J = 6.3 Hz, 1H), 6.90 (d, J = 8.6 Hz, 2H), 6.63 (d, J = 16.0 Hz, 1H), 6.33 
(dt, J = 6.0, 15.9 Hz, 1H), 4.52 (s, 2H), 4.18 (dd, J = 1.4, 6.0 Hz, 2H), 3.82 (s, 3H).    
 
 (E)-1-(((3,7-Dimethylocta-2,6-dien-1-yl)oxy)methyl)-4-methoxybenzene (252).
98 
Prepared by 
General Procedure 3 from the commercially available 4-methoxybezyl-2,2,2-
trichloroacetimidate.
 
Purified by 10% ethyl acetate/90% hexanes solvent system. Clear colored 
oil (0.498 g, 45%). 
1
H NMR (400 MHz, CDCl3) δ 7.33 (d, J = 8.8 Hz, 2H) 6.93 (d, J = 8.8 Hz, 
2H), 5.49 – 5.46 (m, 1H), 5.20 – 5.17 (m, 1H), 5.16 (s, 2H), 4.07 (d, J = 7.2 Hz, 2H), 3.81 (s, 
3H), 2.22 – 2.18 (m, 2H), 2.17 – 2.10 (m, 2H), 1.76 (s, 3H), 1.71 (s, 3H), 1.68 (s, 3H). 
13
 C NMR 
(100 MHz, CDCl3) δ 157.9, 135.8, 129.8, 113.9, 55.3, 40.2. 
13
 C NMR (100 MHz, CDCl3) δ 
159.2, 140.2, 129.43, 124.1, 120.9, 113.8, 71.6, 66.3, 55.3, 39.6, 26.4, 25.7, 17.7, 16.5. 
 
1-methoxy-4-((prop-2-yn-1-yloxy)methyl)benzene (253).
99
  Prepared by General Procedure 3 
from the commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
Purified by 10% 
ethyl acetate/90% hexanes solvent system. Clear colored oil (0.578 g, 82%). TLC Rf = 0.41 (10% 
Ethyl acetate/90% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.32 (d, J = 8.4 Hz, 2 H), 6.93 (d, J = 
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1.8 Hz, 2 H), 4.57 (s, 2 H), 4.17 (d, J = 2.4 Hz, 2 H), 3.82 (s, 3 H), 4.55 (s, 2 H), 2.52 (d, J = 2.4 
Hz, 1 H). 
 
1-methoxy-4-((octadecyloxy)methyl)benzene (239).
100
 Prepared by General Procedure 3 from 
the commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
Purified by 10% ethyl 
acetate/90% hexanes solvent system. White colored solid (0.844 g, 96%). mp = 45.6-46.5°C. 
TLC Rf = 0.82 (10% ethyl acetate/90% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 7.26 (d, J = 8.8 
Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 4.42 (s, 2H), 3.79 (s, 3H), 3.43 (t, J = 6.7 Hz, 2H), 1.63-1.56 
(m, 2H), 1.36-1.25 (m, 34H), 0.88 (t, J = 6.6 Hz,- 3H).    
 
 (2-((4-methoxybenzyl)oxy)ethyl)trimethylsilane (254).
79
 Prepared by General Procedure 3 
from the commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
Purified by 10% 
ethyl acetate/90% hexanes solvent system. Red colored oil (0.558 g, 68%). TLC Rf = 0.76 (10% 
ethyl acetate/90% hexanes); 
1
H NMR (300 MHz, CDCl3) δ 7.25 (d, J = 8.4 Hz, 2H),  6.86 (d, J = 
8.1 Hz, 1H), 4.40 (s, 2H), 3.78 (s, 3H), 3.54 (td, J = 0.9, 8.1 Hz, 2H), 0.97 (td, J = 0.9, 8.1 Hz, 
2H), 0.00 (s, 9H).    
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1-((cyclohexyloxy)methyl)-4-methoxybenzene (255).
89
 Prepared by General Procedure 3 from 
the commercially available 4-methoxybezyl-2,2,2-trichloroacetimidate.
 
 Purified by 10% ethyl 
acetate/90% hexanes solvent system. Yellow colored oil (0.414 g, 47%). 
1
H NMR (300 MHz, 
CDCl3) δ 7.26 (d, J = 8.4 Hz, 2H) 6.86 (d, J = 8.7 Hz, 2H), 4.46 (s, 2H), 3.77 (s, 3H), 3.36 – 3.28 
(m, 1H), 1.95 – 1.90 (m, 2H), 1.75 – 1.70 (m, 2H), 1.55 – 1.48 (m, 1H), 1.39 – 1.28 (m, 5H). 
13
 C 
NMR (100 MHz, CDCl3) δ 157.9, 135.8, 129.8, 113.9, 55.3, 40.2. 
13
 C NMR (75 MHz, CDCl3) δ 
159.0, 131.5, 129.0, 113.7, 69.3, 55.3, 32.3, 25.9, 24.2. 
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Chapter 4. Progress Towards an Efficient Synthesis of AQX-1125 
 
4.1 Introduction 
Phosphoinositides (PIs) are important signaling molecules that make up only a small 
fraction of cellular phospholipids
1
 yet play an integral role in the regulation of many cellular 
processes, including cell proliferation and survival, vesicular trafficking by recruitment of 
effector proteins, and cytoskeletal reorganization. These molecules act as important secondary 
messengers, which are regulated by numerous enzymes, including kinases, phosphatases, and 
phospholipases.
1-17
 The phosphorylation pattern on the inositol plays a critical role in signal 
transduction, so inositol phosphorylation is tightly regulated by inositol kinases and phosphatases 
with aberrant regulation being implicated in numerous human diseases.
18-25 
The structure of the PIs typically contains a glycerol backbone esterified to two fatty acid 
chains and a phosphate which is attached to a polar inositol head group. The polar inositol 
extends into the cytoplasm, while the long alkyl chains intercalate into the cell membrane, 
depicted by PI(4,5)P2 in Figure 7, a common phosphoinositide. The inositol head group is 
typically phosphorylated with the phosphorylation pattern tightly regulated by cytoplasmic lipid 
kinases.
26
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Figure 7: Structure of PI(4,5)P2  
 
Several enzymes are known to functionalize PIs, and one of the most studied are the 
phosphatidylinositol 3-kinases (PI3K).
14
 PI3K is an essential class of lipid kinases which are 
characterized by their ability to phosphorylate the inositol ring at the 3’-OH group on PIs 
(Scheme 26).
27
 The enzyme PI3K (phosphatidylinositol 3-kinase) catalyzes the production of the 
lipid second messenger phosphatidylinositol-3,4,5-triphospate (PI(3,4,5)P3) at the cell membrane 
(Scheme 32). Once PI3K is activated by a nearby receptor tyrosine kinase (RTK) it rapidly forms 
PI(3,4,5)P3 from PI(4,5)P2.
12,23,28,36
 PI(3,4,5)P3 is normally maintained at a low concentration, 
however, upon external stimuli, PI3K can rapidly synthesize its key secondary messenger from 
phosphatidylinositol-4,5-diphospate (PI(4,5)P2).
13
 This formation leads to the recruitment of the 
pleckstrin homology (PH) domains to the cell membrane, more specifically, serine-threonine 
protein kinases, which include protein kinase B (Akt) and phosphoinsoitide kinase I (PDK1), in 
addition to Btk, Src and others, initiating signals of the growth-factor response pathway.
12,23,28,35-
40
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Scheme 26: Enzymatic Synthesis and Degradation of PI(3,4,5)P3
 
Focusing on the PI3K-Akt signaling pathway, it is deeply rooted in the regulation of 
numerous cellular functions that include survival, adhesion, proliferation, differentiation, 
movement, and end-cell activation and has been extensively investigated as they are implicated 
in various human diseases.
14-16,23,28,36
 The identification of this pathway began in earnest in the 
early 1980s with attempts to characterize insulin receptor signaling;
12,35
 however, with the 
discovery of this highly conserved, tightly regulated pathway it's potent contribution to 
tumorigenesis became apparent, and most modern investigations are focused on developing 
cancer treatments.
35
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Scheme 27: Signaling from the PI3K pathway through Akt
 
Phosphatases also regulate the phosphorylation pattern on inositols in the PI3K signaling 
pathway. The phosphatase and tensin homolog (PTEN) and SH2-containing inositiol-5’-
phosphatase (SHIP1 and SHIP2) are common inositol phosphatases involved in processing 
PIP3.
41,42
 PTEN reverses the PI3K reaction, removing a phosphate from the 3' position of the 
inositol, transforming PI(3,4,5)P3 back to PI(4,5)P2. PTEN is well known as a tumor suppressor 
gene
41-43
 that consists of a 403 amino acid protein located on human chromosome 10q23.
23,44,45
 
Complete loss of PTEN is associated with cancer and metastasis, with PTEN knockout mice 
rapidly developing tumors. In PTEN knockouts, there is no enzyme to facilitate the hydrolysis of 
PIP3 to PI(4,5)P2, allowing Akt to become hyperactivated. With hyperactivation, PTEN-deficient 
cells are prevented from undergoing their normal apoptotic stimuli which leads to the abnormal 
growth.
43,46
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In contrast to PTEN, SHIP knockout mice are viable and do not develop cancer, although 
they do posses a modified immune system
47
 and have shortened lifespans. Conversely to PTEN, 
SHIP converts PI(3,4,5)P3 to PI(3,4)P2 and is therefore classified as inositol phospholipid 5’-
phosphatase.
14,23
 Hydrolysis of PI(3,4,5)P3 blocks PI3K effector pathways and thereby inhibits 
additional proteins, including Akt, to increase in concentration. Alternatively, SHIP can also 
promote activation of Akt due to increased affinity of the Akt PH domain for PI(3,4)P2. 
Therefore, SHIP can both negatively and positively influence cellular pathology. Nevertheless, 
blocking either signaling pathway provides a promising approach for treating several types of 
cancer.
48-50
 Additionally, SHIP has an SH2 protein-protein recognition domain, which allows the 
protein to act as a docking partner for a number of other soluble proteins, recruiting their 
enzymatic activity to the plasma membrane.
51,52 
Two major isoforms of SHIP are directly associated with the PI3K pathway, SHIP1 and 
SHIP2. Although these enzymes share a high level of amino acid conservation, they differ 
considerably in tissue distribution and cell signaling.
14,41,42
 SHIP1 is predominantly confined to 
hematopoietic cells,
53
 but is also expressed by osteoblasts and mesenchymal stem cells.
25,53
 
SHIP1 functions as a negative controller in immunoreceptor signaling and hematopoietic 
progenitor cell proliferation/survival, as well as an inducer of cellular apoptosis.
41,43 
In contrast, SHIP2 is more ubiquitous as it is expressed across all cell and tissue types;
14
 
especially high levels of SHIP2 are found in human heart and skeletal muscle cells as well as in 
the placenta.
54
 SHIP2 has been reported to act as a significant negative regulator of the insulin-
signaling pathway and this apparent in SHIP2 knockout mice where they have shown a reduced 
body weight despite increased food intake.
55,56
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4.2 SHIP1 Agonists 
 Since a small variation in the concentration of PI(3,4,5)P3 at the cell membrane plays a 
critical role in signal transduction, the enzymes controlling inositol phosphorylation in the PI3K 
pathway (PI3K, PTEN and SHIP) have become appealing targets for pharmaceutical intervention 
towards finding treatments for a number of disease states.
6,14,57-59
 Inhibition of PI3K has been the 
most hotly pursued approach, with a number of pharmaceutical companies competing heavily in 
this area.
59-61
 In contrast, the phosphatases PTEN and SHIP have received less attention. 
Recently there have been reports of several investigations,
15,17,24
 including several within the 
Chisholm group,
63-66
 that have been completed on SHIP1 antagonists and their effects on the 
PI3K pathway.
68,69
 However, the remainder of this chapter will focus solely on SHIP1 agonists, 
their activity, and respective literature syntheses. 
SHIP1 is known to be an allosterically activated enzyme, with the product of the SHIP1 
phosphatase activity, PI(3,4)P2, binding to the enzyme and accelerating the hydrolysis of the 5'-
phosphate.
14,17,67
 In theory, this binding site may be occupied by other small molecules which 
can accelerate the rate of hydrolysis of PI(3,4,5)P3. Therefore SHIP agonists may provide a novel 
method for the degradation of PI(3,4,5)P3 which could be used to influence signaling associated 
with the PI3K pathway. The acceleration of SHIP would provide a new method for degradation 
of PI(3,4,5)P3 which may be influenced by pharmacological intervention with a small molecule. 
The exploration for small molecule SHIP1 agonists became of particular interest as the 
hyperactivity associated with the PI3K pathway has been shown to facilitate tumor growth as 
well as aggravate conditions related to inflammation and osteoporosis.
14,59
  
In an attempt to find new small molecule SHIP1 agonists, Andersen and co-workers
59
 
screened crude extracts of marine invertebrates. They found that the naturally occurring 
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sesquiterpene pelorol 260 (found in an extract from Dactylospongia elegans harvested in Papua 
New Guinea), was able to enhance SHIP1 phosphatase activity. The first total synthesis of 
pelorol was also developed by the Andersen group, requiring only 9 steps from (+) – 
sclareolide.
59  
Pelorol 260 had been previously isolated by independently by Konig
70
 and 
Schmitz
71
 in 2000 from D. elegans and the Micronesian sponge Petrosadpongia metachromia, 
but the enzymatic target was not previously reported. Also notable is a second synthesis of 
pelorol by Baran, which required 11 steps and proceeded in 8.5% overall yield.
72 
 
Scheme 28: Pelorol Synthesis 
 Since the determination of pelorol's SHIP1 agonist activity, numerous analogs of 260 
have been synthesized and tested for SHIP1 activity. Some of these are seen in Figure 8 
below.
59,68
 Tolyl analogue 261 was synthesized by Yang in six steps from 259. Catechol 261 was 
shown to inhibit degranulation and TNFα production in SHIP1 as well as show anti-
inflammatory effects similar to that of dexamethasone (a known reference standard).
59
 As 
catechols are typically undesired in pharmaceuticals due to the likely production of unwanted 
side effects like metal chelation and the associated toxicity, 262 was synthesized.
14,17,71-75
 
Similarly to 261, this analogue showed comparable potency, preference to SHIP1 over SHIP2, 
and was tolerated well by cells.
17,66
 The pelorol analogs all suffered from poor water solubility 
however, which limited their use in in vivo assays, and clinical development of this class of 
SHIP1 agonists was discontinued for this reason. 
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Figure 8: Pelorol Analogs 
In addition to pelorol and its analogues, Anderson's group was able to find a number of 
other, structurally distinct natural products which act as SHIP1 agonists. For example, Andersen 
and co-workers
73
 isolated and elucidated the structure of australin E (266) from the soft coral 
Cladiella sp. This molecule belongs to the eunicellin diterpenoids and is the first example of a 
SHIP1 agonist from this class of natural products (even though they have previously shown in 
vitro cytotoxicity against cancer cell lines).
76
 Other australin analogs (F and G) were also 
identified in the initial isolate but did not show SHIP1 agonist activity.  
 
Figure 9: Australin E, F, and G  
Another structural class of SHIP1 agonists found by the Anderson group is the cyclic 
depsipeptides (Figure 10). These agonists were isolated from a strain of Bacillus sp. and the 
structures were verified by the synthesis of the linear seco acids followed by macrocyclization 
with a carbodiimide reagent. Turnagainolide B 270 was found to have similar potency as 262, 
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yet 269, which only differs in stereochemistry of the lactone, was found to have no SHIP1 
agonist activity.
77 
 
Figure 10: Turnagainolides A and B  
Aquinox Pharmaceuticals developed an aminosteroid derivative with an open B ring, 
AQX-1125 (Figure 11, 272),
78
 which was likely found by screening a number of indene 
derivatives that were synthesized by Inflazyme Pharmaceuticals.
79
 Aquinox describes a number 
of preclinical studies with AQX-1125, as well as it's advancing to the clinic as an anti-asthmatic 
agent.
80,81 
 While AQX-1125 was not as effective a SHIP1 agonist as pelorol 260, the 
significantly better water solubility of AQX-1125 led to its advancement to the clinic. In 2015, 
272 made it to Phase 2 clinical trials to treat asthma, however it recently was unable to 
demonstrate efficacy in patients with mild to moderate atopic dermatitis, not showing statistical 
significance in the study.
82 
As of January 2016, AQX-1125 has undergone plans with the FDA 
for a Phase 3 clinical trial to be used for the treatment of patients with bladder pain 
syndrome/interstitial cystitis (BPS/IC), which is a chronic inflammatory bladder disease.
83
 AQX-
1125 is the first pharmaceutical agent that specifically targets SHIP1 to reach clinical trials.  
158 
 
 
Figure 11: IPL576,092 & AQX-1125 with SHIP Activation and logP Comparison to 260  
 Aquinox has disclosed only a single synthesis of AQX-1125 through patent literature,
78
 
and also reports a similar intermediate and synthetic route as IPL576,092 (Figure 11, 271).
79
 As 
seen in Scheme 29, the synthetic route begins from trans-dehydroandrosterone 273. Treatment of 
273 with ethylene glycol in the presence of pTsOH provided the ketal 274. The hydroxy group at 
C3 was then protected as a TBS ether. Allylic oxidation of this ether using ruthenium catalysis 
provided enone 276 in 56% overall yield. The authors also employed chromium-trioxide-
dimethylpyrazole which they report obtained a higher yield of 65%; however this uses a 10-fold 
excess of chromium trioxide and therefore is not practical for large-scale work. Stereoselective 
1,2-reduction of the enone using Luche conditions followed by a hydroboration-oxidation of the 
C5-C6 alkene gave an intermediate steroid diol 278. Both the ketal and TBS ether protecting 
groups were then deprotected in a one-step process by treatment of 80% aq. AcOH followed by 
protection of 6αOH and 7βOH as an acetonide, yielding steroid 280.
78
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Scheme 29: Literature Synthesis of AQX-1125 
 
Installation of the C17 alkene was then performed with treatment of ketone 280 with the 
corresponding Wittig reagent to obtain exocyclic olefin 281, which was followed by protection 
of the C3 alcohol as the acetate to provide 282. Hydrolysis of the acetonide to form diol 283 
followed by treatment with NaIO4 in THF to oxidatively cleave the diol provided the open B ring 
dialdehyde 284. The dialdehyde was quickly reduced using NaBH4 and protected as the 
respective monoacetate 286. This protection was reported to be somewhat selective but the yield 
of undesired monoprotected acetate isomer was not given. Amine synthesis resulted from an 
azide displacement of the respective mesylate 287 followed by subsequent reduction employing 
lithium aluminum hydride, 289. To finish the synthesis, they carefully prepared the acetate salt to 
complete the first synthesis of AQX-1125 in 17 steps and 13% overall yield (Scheme 30).
78
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Scheme 30: Literature Synthesis of AQX-1125 
4.3 Synthetic Route 
During our recent studies on the SHIP enzyme some biochemical experiments were 
proposed that would require access to a small molecule SHIP agonist. Attention was then turned 
to the above synthesis of AQX-1125 to determine if it would be feasible to generate enough of 
the agonist to facilitate the biochemical studies. While the synthesis of AQX-1125 certainly has 
proven useful in exploring the interesting chemical space and synthesizing compounds for 
screening, this synthetic route is quite long and involved.
78  
The synthesis seen above in Schemes 
29 and 30 also generates an intermediate (diol 285), which is difficult to selectively manipulate 
resulting in an avoidable loss of material. Efforts were therefore directed to develop a more 
streamlined approach to AQX-1125 that could be used to provide material for biological 
evaluation. 
Examining the structure of AQX-1125, a new retrosynthetic approach was envisioned. 
The major feature differentiating this route would be the focus on intermediates like 290 and 291 
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which have the C6 and C7 carbons in different oxidation states. This would allow for a selective 
manipulation that was not available in the aforementioned synthesis. The retrosynthetic plan 
anticipated the key intermediates would be generated from an allylic oxidation of the C7 
position, ozonolysis of the respective silyl enol ether, an EDCI – mediated amide coupling 
followed by LAH reduction of the amide, and a late stage Wittig (Scheme 31). 
 
Scheme 31: Retrosynthetic Analysis of AQX-1125 272 
The new synthetic route begins with trans-dehydroandrosterone, 273. Dioxolane 
protection of the ketone at C17 and TBS protection of the C3 alcohol both proceeded in excellent 
yields to generate intermediate 275. Allylic oxidation at C7 on alkene 276 was then performed, 
providing a 56% yield of the desired product. While this yield was moderate it was comparable 
to many literature examples.
78,79,84 
A recent report by the Baran group notes that this 
transformation may be performed electrochemically in higher yield, and these conditions may be 
investigated in the future.
85 
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Scheme 32: Synthesis of Ketone 293 
Various attempts were made to complete the olefin reduction of 276 to obtain 293. Initial 
conditions used magnesium in methanol,
 
unfortunately after multiple attempts (Table 24, entries 
1-3) only reduction of the ketone was observed. Transfer hydrogenation utilizing Pd/C and 
ammonium formate was then attempted (entry 4) since the literature showed examples with 
similar steroid substrates;
86  
however, only starting material was obtained. Utilizing catalytic 
hydrogenation (10% Pd/C under one atmosphere of H2 gas) provided the desired product 293 
(entry 7) in 64% yield as the only compound isolated. Literature has shown to yield the trans – 
decalin product selectively in similar steroid systems.
84  
As the C5 hydrogen signal is obscured in 
the 
1
H NMR by other signals, we tentatively assign the product as the trans – decalin. 
Verification of this assignment will be the subject of future work.  
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Table 24: Reduction Attempts of Substrate 276 to 293  
 
The silyl enol ether 292 was then generated from the reduced steroid 293. Ozonolysis 
using a reductive work-up was then utilized to obtain hydroxy-acid 291; this material was 
immediately brought forward to the TBS protected intermediate 294. Key intermediate 290 was 
then accessed by an EDCI – mediated amide coupling using ammonium hydroxide; although this 
reaction proved capricious (giving product only twice despite multiple attempts) and purification 
of 290 proved to be difficult.  
 
Scheme 33: Synthesis of Amide 290 
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To complete the synthesis of AQX-1125, the synthetic route would require deprotection 
of the dioxolane utilizing 80% aq. AcOH to regenerate the ketone at C17; however, every time 
this reaction was attempted, degradation occurred and no product or starting materials was 
isolated. This may be due to the loss of the C6 silyl ether, which then facilitates amide 
hydrolysis. The corresponding acid generated from this reaction is likely difficult to separate or 
recover from AcOH. Nevertheless, we can still report our proposed end-game towards 272, 
which would include a Wittig reaction to obtain the methylene at C17. An LiAlH4 reduction to 
the amine 297, deprotection of the silyl enol ether utilizing TBAF and generation of the acetate 
salt would complete the synthesis of AQX-1125 272.  
Scheme 34: Proposed End-Game Towards Synthesis of AQX-1125  
 Due to the consistently low yields in the formation of the amide and difficulties in 
deprotection of C17, two alternative syntheses to our original route have been proposed. The first 
features an alternative method to obtain the required amine 302, seen in Scheme 35. This route 
still proceeds through ozonized 291 but after subsequent protection of the hydroxyl group, the 
manipulation to the amine would result from reduction of the ensuing azide displacement of the 
mesylate. 
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Scheme 35: Proposed Alternate Synthesis Towards Amine 302 
  We could imagine deprotection at C17 would still prove difficult in this substrate, so we 
envision that lactone intermediate 305 may be more suitable towards such conditions and yield the 
desired unprotected ketone (Scheme 36). This would be obtained from a new route to the 
respective hydroxy-acid 291 via a Rubottom oxidation, followed by NaIO4 in THF to oxidatively 
cleave to yield the open B ring, and selective reduction of the aldehyde utilizing NaBH4. 
Subsequent lactonization of 291 using EDCI would then yield 305. We chose to propose an 
alternate route to 291 as ozonolysis may not be scalable. Once 305 was obtained, the alkene could 
be installed at C17 and the lactone could be opened with ammonia to directly access the 
corresponding amide. The amide can then be reduced to the amine, accessing AQX-1125 after 
deprotection of the silyl ether. 
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Scheme 36: Proposed Alternate Synthesis Towards Protected Exocyclic Olefin 309 
 
4.4 Summary 
 The PI3K pathway is a major signaling axis and since its identification there have been 
numerous efforts made to develop a targeted therapy, specifically PI3K inhibitors or SHIP 
agonists/antagonists; however most have limited efficacy.  Of these agents, only a single small 
molecule SHIP modulator has been advanced to clinical trials, AQX-1125. The illustrated 
synthetic route Aquinox Pharmaceuticals took to develop AQX-1125 is quite long and not very 
efficient.
78
 The route generates a pseudosymmetrical intermediate 285 with two primary alcohols 
that require selective manipulation. A new synthetic route to AQX-1125 was investigated to 
develop a more concise process proceeding through a more manageable intermediate as a key 
intermediate. This proposed synthesis, once complete, would require 13 steps to obtain AQX-
1125, which is significantly more efficient. Although some portions of this synthesis proved 
difficult, specifically the amine formation and ketal deprotection, alternative routes have been 
proposed and the Chisholm group will continue to explore these alternatives.  
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4.5 Experimental 
 
General Methods: All anhydrous reactions were run under a positive pressure of argon or 
nitrogen. All syringes, needles, and reaction flasks required for anhydrous reactions were dried in 
an oven and cooled under an N2 atmosphere or in a desiccator. Dichloromethane and THF were 
dried by passage through an alumina column following the method of Grubbs (Pangborn, A. B.; 
Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518). 
Triethylamine was distilled from CaH2. All other reagents and solvents were purchased from 
commercial sources and used without further purification.  
Analysis and Purification. Analytical thin layer chromatography (TLC) was performed on 
precoated glass backed plates (silica gel 60 F254; 0.25 mm thickness). The TLC plates were 
visualized by UV illumination and by staining. Solvents for chromatography are listed as 
volume:volume ratios. Flash column chromatography was carried out on silica gel (40-63 μm). 
Melting points were recorded using an electrothermal melting point apparatus and are 
uncorrected. Elemental analyses were performed on an elemental combustion system ECS 4010 
analyzer with a thermal conductivity detector and 2 meter GC column maintained at 50 °C. 
Identity. Proton (
1
H NMR) and carbon (
13
C NMR) nuclear magnetic resonance spectra were 
recorded at 300 or 400 MHz and 75 or 100 MHz respectively. The chemical shifts are given in 
parts per million (ppm) on the delta (δ) scale. Coupling constants are reported in hertz (Hz). The 
spectra were recorded in solutions of deuterated chloroform (CDCl3), with residual chloroform (δ 
7.26 ppm for 
1
H NMR, δ 77.23 ppm for 
13
C NMR) or tetramethylsilane (δ 0.00 for 
1
H NMR, δ 
0.00 ppm for 
13
C NMR) as the internal reference. Data are reported as follows: (s = singlet; d = 
doublet; t = triplet; q = quartet; p = pentet; dd = doublet of doublets; dt = doublet of triplets; td = 
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triplet of doublets; tt = triplet of triplets; qd = quartet of doublets; ddd = doublet of doublet of 
doublets; br s = broad singlet). Where applicable, the number of protons attached to the 
corresponding carbon atom was determined by DEPT 135 NMR. Infrared (IR) spectra were 
obtained as thin films on NaCl plates by dissolving the compound in CH2Cl2 followed by 
evaporation or as KBr pellets. 
 
5-androsten-3β-ol-17-ethylene ketal, 274
79 
Trans-dehydroandrosterone 273 (0.504 g, 1.73 mmol) was added to a 50 mL flame dried round-
bottom flask. 5 mL of dry Benzene was added to suspend the trans-dehydroandrosterone. p-
Toluene sulfonic acid monohydrate (0.013 g, 0.066 mmol) and ethylene glycol (0.5 mL) were 
then added to the reaction. This reaction mixture was heated to reflux under a Dean-Stark trap 
for 4.5 hours under argon. The mixture was removed from heat and allowed to cool to rt. The 
excess benzene was removed under reduced pressure. The remaining contents were diluted with 
diethyl ether (50 mL) and washed successively with saturated NaHCO3 (2 x 25 mL) and 
saturated NaCl (25 mL). The organic layer was dried with anhydrous NaSO4 and removed under 
reduced pressure to yield a white colored solid (0.558 g, 96%). TLC Rf  = 0.28 (30% ethyl 
acetate /70% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 5.36 – 5.34 (m, 1H), 3.95 – 3.84 (m, 4H), 
3.57 – 3.49 (m, 1H), 2.33 – 2.19 (m, 2H), 2.04 – 1.98 (m, 2H), 1.88 – 1.78 (m, 3H), 1.77 – 1.28 
(m, 12H), 1.22 (m, 2H), 1.01 (s, 3H), 0.86 (s, 3H).  
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5-androsten-3β-ol-17-ethylene ketal tert-butyldimethylsilyl ether, 275
79 
5-androsten-3β-ol-17-one ethylene ketal 274 (0.501 g, 1.50 mmol) was added to a 50 mL flame 
dried round-bottom flask. 2.7 mL of DMF and 2.7 mL of CH2Cl2 were added to dissolve the 
ketal. Imidazole (0.255 g, 3.67 mmol) and tert-butyl (chloro) dimethyl silane (0.347 g, 2.32 
mmol) were then added to the reaction. This reaction mixture was allowed to stir at rt for 6 hours 
under argon. The excess solvent was removed under reduced pressure. The remaining contents 
were diluted with diethyl ether (50 mL) and washed successively with 5% aqueous HCl (2 x 100 
mL), saturated NaHCO3 (2 x 25 mL) and saturated NaCl (25 mL). The organic layer was dried 
with anhydrous NaSO4 and removed under reduced pressure to yield a white colored solid (0.624 
g, 93%). TLC Rf  = 0.74 (30% ethyl acetate /70% hexanes); 
1
H NMR (400 MHz, CDCl3) δ 5.36 
– 5.34 (m, 1H), 3.95 – 3.84 (m, 4H), 3.57 – 3.49 (m, 1H), 2.33 – 2.04 (m, 2H), 2.02 – 1.88 (m, 
2H), 1.79 – 1.76 (m, 3H), 1.76 – 1.22 (m, 12H), 1.22 (m, 2H), 1.01 (s, 3H), 0.86 (s, 9H), 0.00 (s, 
3H).  
 
5-androsten-7-one-3β-ol 17-ethylene ketal tert-butyldimethylsilyl ether, 276
79 
5-androsten-3β-ol-17-one ethylene ketal tert-butyldimethylsilyl ether 275 (0.252 g, 0.55 mmol) 
was added to a 25 mL flame dried round-bottom flask. 1.0 mL of cyclohexane and 0.15 mL of 
water were added to dissolve the ketal. Ruthenium trichloride hydrate (0.001 g, catalytic) was 
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then added to the reaction. 70% tert-Butyl hydroperoxide (0.65 mL) was added dropwise at 0°C. 
This reaction mixture was allowed to come to rt and stir for 18 hours under argon. Then an 
additional 1.0 mL of cyclohexane was added and this was allowed to stir at rt for 2 additional 
hours. The mixture was diluted with ethyl acetate (50 mL) and washed successively with 25% 
aqueous Na2SO4 (2 x 50 mL) and saturated NaCl (25 mL). The organic layer was dried with 
anhydrous NaSO4 and removed under reduced pressure to yield a white colored solid (0.142 g, 
56%). 
1
H NMR (300 MHz, CDCl3) δ 5.60 (s, 1 H), 3.95 – 3.84 (m, 4 H), 3.59 – 3.49 (m, 1 H), 
2.46 – 2.42 (m, 3H), 2.29 – 2.18 (m, 1H), 1.66 – 1.34(m, 13 H), 1.12 (s, 3 H), 0.83 (s, 9 H), 0.80 
(s, 3 H), 0.00 (s, 3 H).  
 
5-androsta-7-one-3β-ol 17-ethylene ketal tert-butyldimethylsilyl ether, 293
 
To a 25 mL flame-dried round bottom flask, 0.048 g of 10% Pd/C was added and dissolved in 
6.0 mL of dioxane and 2.0 mL of ethanol. This was placed under vacuum until bubbling 
occurred in which a hydrogen balloon was added and deflated under vacuum. The vacuum was 
then removed and a hydrogen balloon was placed. In a separate flame dried conical flask, 5-
androsten-7, 17-dione-3β-ol 17-ethylene ketal tert-butyldimethylsilyl ether 276 was dissolved in 
9.0 mL of dioxane. This was placed under vacuum and a hydrogen balloon was added. This 
mixture was then transferred under hydrogen to the initial mixture. This was allowed to stir for 7 
hours at rt. This was then filtered through celite, rinsing with ethyl acetate. This was 
concentrated under reduced pressure and subjected to column chromatography (10% ethyl 
acetate/90% hexanes) to yield a white colored solid (0.312 g, 64%). mp = 198.5 – 200.3°C; TLC 
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Rf  = 0.67 (15% ethyl acetate /85% hexanes); IR (neat) 2950, 2857, 1703 cm
-1
; 
1
H NMR (300 
MHz, CDCl3) 3.91 – 3.77 (m, 4 H), 3.59 – 3.47 (m, 1 H), 2.32 – 2.19 (m, 3 H), 1.99 – 1.31 (m, 
15 H), 0.99 (s, 3 H), 0.84 (s, 9 H), 0.79 (s, 3 H), 0.00 (s, 3 H). 
13
C NMR (75 MHz, CDCl3): δ 
211.4, 118.7, 71.4, 65.2, 64.4, 55.3, 50.1, 46.6, 45.9, 45.7, 43.4, 38.4, 36.3, 35.9, 34.1, 31.5, 29.7, 
25.8, 23.8, 21.3, 18.2, 14.4, 11.8, -4.66.  
 
5-androsta -7 – tert-butyldimethyl oxysilane -3β-ol 17-ethylene ketal tert-butyldimethylsilyl 
ether, 292
 
1.2 mL of triethylamine (8.8 mmol) and 0.5 mL of CH2Cl2 were placed in a 50 mL flame dried 
round-bottom flask and was placed at 0°C. 5-androsta-7-one-3β-ol 17-ethylene ketal tert-
butyldimethylsilyl ether, 293 (0.104 g, 0.22 mmol) was dissolved in 1.5 mL of CH2Cl2 and was 
then added dropwise to the stirring solution. This was allowed to stir at this temperature for 15 
minutes. Tert-butyldimethylsilyl trifluoromethane sulfonate (0.8 mL, 15.1 mmol) was then added 
to the reaction, maintaining 0°C. This reaction mixture was placed at rt and allowed to stir for 4 
hours under argon. This was re-placed at 0°C and isopropyl alcohol (0.40 mL) was then added. 
This was then filtered through celite, rinsing with CH2Cl2. This was concentrated under reduced 
pressure and subjected to column chromatography (10% ethyl acetate/90% hexanes) to yield a 
pale yellowish-white colored solid (0.120 g, 94%). TLC Rf  = 0.58 (10% ethyl acetate /90% 
hexanes); 
1
H NMR (400 MHz, CDCl3) δ 4.36 (s, 1H), 3.93 – 3.79 (m, 4H), 3.61 – 3.53 (m, 1H), 
1.95 – 1.85 (m, 4 H), 1.84 – 1.45 (m, 11 H), 1.14 – 1.39 (m, 4 H), 1.16 - 0.89 (m, 45 H), 0.79 (s, 
3 H), 0.00 (s, 12 H). 
13
C NMR (100 MHz, CDCl3): δ 152.2, 118.7, 108.4, 72.1, 65.2, 64.5, 53.9, 
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48.6, 47.5, 43.4, 42.0, 39.4, 34.9, 34.5, 34.3, 31.9, 30.8, 26.1, 25.9, 25.7, 25.70, 20.9, 18.3, 18.2, 
18.1, 14.7, 11.3, -2.9, -3.9, -4.8, -4.6, -4.57. 
 
(7a'S)-5'-((1R,4S)-4-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)-1-methylcyclohexyl)-
7a'-methyloctahydrospiro[[1,3]dioxolane-2,1'-indene]-4'-carboxylic acid, 291 
5-androsta -7 – tert-butyldimethyl oxysilane -3β-ol 17-ethylene ketal tert-butyldimethylsilyl 
ether, 292 (2.58 g, 4.46 mmol) was dissolved in methanol (25 mL) and CH2Cl2 (25 mL) and was 
treated with excess O3 at -78 °C until the solution turned blue. After purging with argon, the blue 
color dissipated. This was placed at 0 °C and sodium borohydride (1.781 g, 26.9 mmol) was 
added. This was then placed at rt and allowed to stir for 4 hours. After the solvent was 
evaporated on a rotary evaporator, the residue was stirred with 10% aq. HCl (20 mL) for 10 
minutes and was then extracted with CH2Cl2 (2 × 50 mL), saturated NH4Cl (50 mL) and 
saturated NaCl (50 mL). The organic layer was dried with anhydrous NaSO4 and removed under 
reduced pressure to yield a cream colored foam (1.04 g, 47%). TLC Rf  = 0.46 (5% DCM /95% 
MeOH). This was used in the next reaction without further purification. 
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(4'R,7a'S)-5'-((1R,4S)-4-((tert-butyldimethylsilyl)oxy)-2-(((tert-
butyldimethylsilyl)oxy)methyl)-1-methylcyclohexyl)-7a'-
methyloctahydrospiro[[1,3]dioxolane-2,1'-indene]-4'-carboxylic acid, 294 
(7a'S)-5'-((1R,4S)-4-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)-1-methylcyclohexyl)-7a'-
methyloctahydrospiro[[1,3]dioxolane-2,1'-indene]-4'-carboxylic acid, 291 
 (0.770 g, 1.55 mmol) was added to a 50 mL flame dried round-bottom flask. 3.0 mL of DMF 
and 3.0 mL of CH2Cl2 were added to dissolve the carboxylic acid. Imidazole (0.268 g, 3.77 
mmol) and tert-butyl (chloro) dimethyl silane (0.362 g, 2.52 mmol) were then added to the 
reaction. This reaction mixture was allowed to stir at rt for 6 hours under argon. The excess 
solvent was removed under reduced pressure. The remaining contents were diluted with diethyl 
ether (50 mL) and washed successively with 5% aqueous HCl (2 x 100 mL), saturated NaHCO3 
(2 x 25 mL) and saturated NaCl (25 mL). The organic layer was dried with anhydrous NaSO4 
and removed under reduced pressure to yield a whit colored solid (0.878 g, 93%). mp = 79.5 – 
81.1°C; TLC Rf  = 0.33 (30% ethyl acetate /70% hexanes); IR (neat) 3390, 2929, 2857, 1808, 
1736, 1703 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 3.91 – 3.79 (m, 4 H), 3.64 – 3.61 (m, 1 H), 3.43 
– 3.38 (m, 1 H), 3.12 (t, J = 9.2 Hz, 1 H), 2.29 (t, J = 10.8 Hz, 1 H), 1.98 – 1.03 (m, 25 H), 0.88 
– 0.83 (m, 29 H), 0.06 – 0.02 (m, 12 H). 
13
C NMR (100 MHz, CDCl3): δ 181.5, 118.6, 108.4, 
72.1, 65.2, 64.5, 62.5, 47.6, 46.0, 45.0, 44.9, 42.5, 37.7, 34.5, 33.6, 31.5, 30.4, 29.8, 25.96, 25.94, 
22.9, 30.6, 19.3, 18.3, 18.2, 13.7, -4.6, -5.32, -5.34. 
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(4'R,7a'S)-5'-((1R,4S)-4-((tert-butyldimethylsilyl)oxy)-2-(((tert-
butyldimethylsilyl)oxy)methyl)-1-methylcyclohexyl)-7a'-
methyloctahydrospiro[[1,3]dioxolane-2,1'-indene]-4'-carboxamide, 290 
(4'R,7a'S)-5'-((1R,4S)-4-((tert-butyldimethylsilyl)oxy)-2-(((tert-butyldimethylsilyl)oxy)methyl)-
1-methylcyclohexyl)-7a'-methyloctahydrospiro[[1,3]dioxolane-2,1'-indene]-4'-carboxylic acid, 
294  was dissolved in 10.0 mL of DMF. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (0.827 
g, 1.35 mmol) was then added. This was allowed to stir at rt for 1 hour. The reaction was placed 
at 0 °C and ammonium hydroxide (0.7 mL) dissolved in 2.0 mL of DMF was added dropwise. 
This was allowed to stir at rt for 4 hours. The excess solvent was removed under reduced 
pressure. The remaining contents were diluted with diethyl ether (50 mL) and washed 
successively with saturated NaHCO3 (2 x 25 mL), 20% aqueous HCl (2 x 50 mL), and saturated 
NaCl (25 mL). The organic layer was dried with anhydrous NaSO4 and removed under reduced 
pressure to yield a pale yellow colored oil (0.257 g, 31%). TLC Rf  = 0.15 (30% ethyl acetate 
/70% hexanes); IR (neat) 3342, 3178, 2952, 2930, 2883, 2558, 1730 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 3.93 – 3.79 (m, 4 H), 3.64 – 3.61 (m, 1 H), 3.44 – 3.38 (m, 1 H), 3.12 (t, J = 9.2 Hz, 1 
H), 2.29 (t, J = 11.2 Hz, 1 H), 1.98 – 1.79 (m, 4 H), 1.51 – 1.42 (m, 10 H), 1.41 – 1.39 (m, 6 H), 
1.22 – 1.18 (m, 2 H), 0.85 – 0.78 (m, 25 H), 0.015 – 0.011 (m, 12 H). 
13
C NMR (100 MHz, 
CDCl3): δ 182.8, 118.7, 108.4, 72.1, 65.2, 64.5, 62.5, 47.6, 46.0, 45.0, 44.9, 42.5, 37.7, 34.5, 
33.6, 31.5, 30.4, 29.8, 25.96, 25.94, 22.9, 30.6, 19.3, 18.3, 18.2, 13.7, -4.6, -5.32, -5.35. 
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